id sid eid entity type bptjm-17 1 1 berkeley pharma tech journal ORG bptjm-17 2 1 june 29, 2021 DATE bptjm-17 2 2 2021 CARDINAL bptjm-17 2 3 december 17, 2021 DATE bptjm-17 2 4 4.0 CARDINAL bptjm-17 3 1 microrna ORG bptjm-17 3 2 mirna PERSON bptjm-17 5 1 mirna PERSON bptjm-17 6 1 mirna PERSON bptjm-17 7 1 carolyn skotz PERSON bptjm-17 7 2 samrat thapa PERSON bptjm-17 7 3 mary nowak PERSON bptjm-17 7 4 hoc lan phung ORG bptjm-17 7 5 akshitha ORG bptjm-17 7 6 mabel ho circulating PERSON bptjm-17 7 7 microrna ORG bptjm-17 8 1 13% PERCENT bptjm-17 8 2 24% PERCENT bptjm-17 8 3 the united states GPE bptjm-17 8 4 each year DATE bptjm-17 9 1 two CARDINAL bptjm-17 9 2 80% PERCENT bptjm-17 10 1 only 19% PERCENT bptjm-17 11 1 2020 DATE bptjm-17 14 1 hundreds CARDINAL bptjm-17 14 2 each year DATE bptjm-17 14 3 rinaldi et al. ORG bptjm-17 14 4 2011 DATE bptjm-17 17 1 2019 DATE bptjm-17 19 1 mirna PERSON bptjm-17 22 1 2017 DATE bptjm-17 23 1 microrna PERSON bptjm-17 23 2 mirna PERSON bptjm-17 24 1 wang et al. PERSON bptjm-17 24 2 2018 DATE bptjm-17 25 1 mirna PERSON bptjm-17 25 2 2 CARDINAL bptjm-17 25 3 3 CARDINAL bptjm-17 26 1 three CARDINAL bptjm-17 27 1 berkeley pharma tech journal ORG bptjm-17 27 2 117 CARDINAL bptjm-17 27 3 stein GPE bptjm-17 27 4 n.d. GPE bptjm-17 28 1 mirna PERSON bptjm-17 30 1 1 CARDINAL bptjm-17 31 1 1 CARDINAL bptjm-17 31 2 mirna PERSON bptjm-17 32 1 mirna PERSON bptjm-17 34 1 1 CARDINAL bptjm-17 37 1 2 CARDINAL bptjm-17 37 2 immunohistochemistry ORG bptjm-17 37 3 ihc ORG bptjm-17 37 4 ihc ORG bptjm-17 39 1 berkeley pharma tech journal ORG bptjm-17 39 2 118 CARDINAL bptjm-17 39 3 2020 DATE bptjm-17 40 1 3 CARDINAL bptjm-17 41 1 first ORDINAL bptjm-17 41 2 two CARDINAL bptjm-17 42 1 second ORDINAL bptjm-17 44 1 millions CARDINAL bptjm-17 44 2 waters & shapter ORG bptjm-17 44 3 2014 DATE bptjm-17 45 1 4. CARDINAL bptjm-17 46 1 three CARDINAL bptjm-17 46 2 a. illumina PERSON bptjm-17 47 1 454 CARDINAL bptjm-17 47 2 454 CARDINAL bptjm-17 49 1 2 CARDINAL bptjm-17 52 1 berkeley pharma tech journal ORG bptjm-17 52 2 119 CARDINAL bptjm-17 52 3 2020 DATE bptjm-17 52 4 al. PERSON bptjm-17 52 5 2014 DATE bptjm-17 53 1 ercc1 PERSON bptjm-17 53 2 1 CARDINAL bptjm-17 53 3 ercc1 PERSON bptjm-17 55 1 ercc1 PERSON bptjm-17 56 1 ercc1 PERSON bptjm-17 56 2 ercc1 PERSON bptjm-17 56 3 li et al. PERSON bptjm-17 56 4 2016 DATE bptjm-17 57 1 ercc1 PERSON bptjm-17 57 2 hamilton et al. PERSON bptjm-17 57 3 2018 DATE bptjm-17 58 1 two CARDINAL bptjm-17 59 1 pd-l1 GPE bptjm-17 59 2 ercc1 PERSON bptjm-17 59 3 83 CARDINAL bptjm-17 60 1 ercc1 PERSON bptjm-17 61 1 0.0001 CARDINAL bptjm-17 61 2 li et al. PERSON bptjm-17 61 3 2016 DATE bptjm-17 61 4 hamilton et al. PERSON bptjm-17 61 5 2018 DATE bptjm-17 62 1 ercc1 PERSON bptjm-17 62 2 ercc1 PERSON bptjm-17 62 3 2019 DATE bptjm-17 63 1 ercc1 PERSON bptjm-17 66 1 berkeley pharma tech journal ORG bptjm-17 66 2 120 CARDINAL bptjm-17 69 1 2017 DATE bptjm-17 71 1 167 CARDINAL bptjm-17 71 2 pfs PERSON bptjm-17 72 1 84 CARDINAL bptjm-17 72 2 83 CARDINAL bptjm-17 73 1 3.8 months DATE bptjm-17 73 2 2.3 months DATE bptjm-17 73 3 2011 DATE bptjm-17 74 1 deng et al PERSON bptjm-17 75 1 one CARDINAL bptjm-17 76 1 20-40% PERCENT bptjm-17 77 1 deng et al. PERSON bptjm-17 77 2 2018 DATE bptjm-17 78 1 7 CARDINAL bptjm-17 78 2 panitumumab PERSON bptjm-17 78 3 cetuximab PERSON bptjm-17 79 1 kras mutations PERSON bptjm-17 81 1 5-20% PERCENT bptjm-17 81 2 2013 DATE bptjm-17 83 1 ntrk ORG bptjm-17 83 2 ntrk ORG bptjm-17 84 1 three CARDINAL bptjm-17 84 2 ntrk1, ntrk2 ORG bptjm-17 84 3 ntrk3 GPE bptjm-17 85 1 berkeley pharma tech journal ORG bptjm-17 85 2 121 CARDINAL bptjm-17 86 1 ntrk1, ntrk2 ORG bptjm-17 86 2 ntrk3 PERSON bptjm-17 86 3 2-3% PERCENT bptjm-17 88 1 ntrk ORG bptjm-17 88 2 loxo-101 PRODUCT bptjm-17 88 3 2017 DATE bptjm-17 89 1 1,378 CARDINAL bptjm-17 89 2 ntrk1, ntrk2, ntrk3 ORG bptjm-17 89 3 two CARDINAL bptjm-17 89 4 multiplex pcr ORG bptjm-17 90 1 one CARDINAL bptjm-17 90 2 45-year-old DATE bptjm-17 90 3 400 mg/m2 QUANTITY bptjm-17 90 4 daily DATE bptjm-17 91 1 26 days DATE bptjm-17 92 1 155 days DATE bptjm-17 92 2 77% PERCENT bptjm-17 92 3 al. PERSON bptjm-17 92 4 2015 DATE bptjm-17 94 1 kim et al. PERSON bptjm-17 94 2 2015 DATE bptjm-17 95 1 wirtz ORG bptjm-17 95 2 2014 DATE bptjm-17 97 1 2018 DATE bptjm-17 97 2 2019 DATE bptjm-17 98 1 liu et al. PERSON bptjm-17 98 2 2020 DATE bptjm-17 99 1 wen et al PERSON bptjm-17 99 2 5.1 to 21.5 percent PERCENT bptjm-17 99 3 23.2 CARDINAL bptjm-17 99 4 43.6 percent PERCENT bptjm-17 100 1 1200 CARDINAL bptjm-17 100 2 chinese NORP bptjm-17 100 3 atlas PERSON bptjm-17 100 4 american NORP bptjm-17 100 5 european NORP bptjm-17 100 6 wen et al. PERSON bptjm-17 100 7 2019 DATE bptjm-17 101 1 liu et al. PERSON bptjm-17 102 1 berkeley pharma tech journal ORG bptjm-17 102 2 122 CARDINAL bptjm-17 102 3 2,5 CARDINAL bptjm-17 102 4 tetrazolium CARDINAL bptjm-17 104 1 atlas survival analysis WORK_OF_ART bptjm-17 105 1 2015 DATE bptjm-17 105 2 zeng et al. PERSON bptjm-17 105 3 2018 DATE bptjm-17 105 4 dacic et al. PERSON bptjm-17 105 5 2008 DATE bptjm-17 106 1 liu et al. PERSON bptjm-17 106 2 2020 DATE bptjm-17 109 1 one CARDINAL bptjm-17 109 2 81.6% PERCENT bptjm-17 109 3 mao et al. PERSON bptjm-17 109 4 2017 DATE bptjm-17 110 1 2020 DATE bptjm-17 112 1 ret ORG bptjm-17 112 2 ret ORG bptjm-17 112 3 approximately 1% to 2% PERCENT bptjm-17 112 4 kohno et al. PERSON bptjm-17 112 5 2013 DATE bptjm-17 112 6 kato et al. PERSON bptjm-17 112 7 2017 DATE bptjm-17 113 1 ret ORG bptjm-17 114 1 ret ORG bptjm-17 114 2 berkeley pharma tech journal ORG bptjm-17 114 3 123 CARDINAL bptjm-17 115 1 pi3k PERSON bptjm-17 115 2 mapk ORG bptjm-17 115 3 2017 DATE bptjm-17 116 1 fda ORG bptjm-17 116 2 ret ORG bptjm-17 116 3 ret ORG bptjm-17 116 4 ret ORG bptjm-17 117 1 ret ORG bptjm-17 117 2 al. PERSON bptjm-17 117 3 2015 DATE bptjm-17 118 1 kodama et al PERSON bptjm-17 118 2 ret ORG bptjm-17 118 3 ccdc6 ORG bptjm-17 118 4 kif5b GPE bptjm-17 119 1 ret ORG bptjm-17 121 1 the steric e ORG bptjm-17 121 2 kodama et al. PERSON bptjm-17 121 3 2014 DATE bptjm-17 122 1 mao et PERSON bptjm-17 123 1 ret ORG bptjm-17 123 2 96.2% PERCENT bptjm-17 124 1 40 CARDINAL bptjm-17 124 2 18-80 DATE bptjm-17 124 3 mao et al. PERSON bptjm-17 124 4 2017 DATE bptjm-17 125 1 one CARDINAL bptjm-17 125 2 as low as 3.5% PERCENT bptjm-17 125 3 45 CARDINAL bptjm-17 125 4 2017 DATE bptjm-17 126 1 ret ORG bptjm-17 126 2 ret ORG bptjm-17 126 3 yang et al. PERSON bptjm-17 126 4 2018 DATE bptjm-17 126 5 thompson et al. PERSON bptjm-17 126 6 2016 DATE bptjm-17 127 1 2 CARDINAL bptjm-17 127 2 2 CARDINAL bptjm-17 127 3 berkeley pharma tech journal ORG bptjm-17 127 4 124 CARDINAL bptjm-17 127 5 2015 DATE bptjm-17 128 1 chuang et al. PERSON bptjm-17 128 2 2017 DATE bptjm-17 129 1 erbb2 GPE bptjm-17 129 2 de melo gagliato et ORG bptjm-17 129 3 2016 DATE bptjm-17 129 4 chuang et al. PERSON bptjm-17 129 5 2017 CARDINAL bptjm-17 129 6 veatch et al. PERSON bptjm-17 129 7 2019 DATE bptjm-17 130 1 garrido-castro PERSON bptjm-17 130 2 felip, 2004 DATE bptjm-17 131 1 her1 ORG bptjm-17 131 2 de melo gagliato et ORG bptjm-17 131 3 2016 DATE bptjm-17 132 1 approximately 1-5% CARDINAL bptjm-17 132 2 erbb2/ her2 PERSON bptjm-17 132 3 1-2% PERCENT bptjm-17 132 4 kris et al. PERSON bptjm-17 132 5 2015 DATE bptjm-17 132 6 chuang et al. PERSON bptjm-17 132 7 2017 DATE bptjm-17 133 1 mao et al PERSON bptjm-17 133 2 erbb2 GPE bptjm-17 133 3 96.2% PERCENT bptjm-17 133 4 2017 CARDINAL bptjm-17 134 1 chuang et al PERSON bptjm-17 134 2 nine CARDINAL bptjm-17 134 3 seven CARDINAL bptjm-17 134 4 2013-2016 DATE bptjm-17 134 5 two CARDINAL bptjm-17 134 6 2014-2015 DATE bptjm-17 136 1 erbb2 GPE bptjm-17 136 2 geneseq PERSON bptjm-17 136 3 pro ling ORG bptjm-17 137 1 1.1 CARDINAL bptjm-17 138 1 44% PERCENT bptjm-17 139 1 erbb2/ her2 PERSON bptjm-17 140 1 erbb2 GPE bptjm-17 142 1 chuang et al. PERSON bptjm-17 142 2 2017 DATE bptjm-17 143 1 berkeley pharma tech journal ORG bptjm-17 143 2 |125 PRODUCT bptjm-17 148 1 one CARDINAL bptjm-17 149 1 anti-her2 pertuzumab NORP bptjm-17 149 2 2019 DATE bptjm-17 150 1 29 CARDINAL bptjm-17 150 2 96.6% PERCENT bptjm-17 152 1 2019 DATE bptjm-17 155 1 hu et al. PERSON bptjm-17 155 2 2019 DATE bptjm-17 155 3 remon et al. PERSON bptjm-17 155 4 2020 DATE bptjm-17 155 5 2020 DATE bptjm-17 156 1 hu et al. PERSON bptjm-17 156 2 2019 DATE bptjm-17 156 3 2020 DATE bptjm-17 157 1 remon et al. PERSON bptjm-17 159 1 berkeley pharma tech journal ORG bptjm-17 159 2 126 CARDINAL bptjm-17 160 1 5.3% PERCENT bptjm-17 160 2 20 CARDINAL bptjm-17 160 3 379 CARDINAL bptjm-17 160 4 only 2.1% PERCENT bptjm-17 161 1 brca ORG bptjm-17 161 2 brca ORG bptjm-17 161 3 ihc ORG bptjm-17 161 4 brca1 GPE bptjm-17 161 5 2020 DATE bptjm-17 162 1 al. ORG bptjm-17 162 2 2005 DATE bptjm-17 164 1 remon et al. PERSON bptjm-17 164 2 2020 DATE bptjm-17 165 1 ramon et al. ORG bptjm-17 165 2 ji et al PERSON bptjm-17 166 1 brca1 GPE bptjm-17 166 2 brca2 PERSON bptjm-17 167 1 2020 DATE bptjm-17 168 1 brca1 GPE bptjm-17 168 2 2011 DATE bptjm-17 169 1 brca1 ORG bptjm-17 170 1 brca1 GPE bptjm-17 170 2 1.72 CARDINAL bptjm-17 170 3 wang et al. PERSON bptjm-17 170 4 2015 DATE bptjm-17 171 1 wang et al. PERSON bptjm-17 171 2 2015 DATE bptjm-17 172 1 yang et al. PERSON bptjm-17 172 2 2016 DATE bptjm-17 173 1 berkeley pharma tech journal ORG bptjm-17 173 2 127 CARDINAL bptjm-17 173 3 pip3 ORG bptjm-17 174 1 pten PERSON bptjm-17 174 2 pip3 NORP bptjm-17 174 3 akt PERSON bptjm-17 174 4 p-akt ORG bptjm-17 175 1 p-akt ORG bptjm-17 175 2 2006 DATE bptjm-17 177 1 one CARDINAL bptjm-17 177 2 ge tinib ORG bptjm-17 177 3 2018 DATE bptjm-17 179 1 ge tinib ORG bptjm-17 179 2 wu PERSON bptjm-17 179 3 loong GPE bptjm-17 179 4 2018 DATE bptjm-17 179 5 lee et al. PERSON bptjm-17 179 6 2006 DATE bptjm-17 180 1 ge tinib ORG bptjm-17 180 2 p<0.017 PERSON bptjm-17 180 3 2018 DATE bptjm-17 181 1 wu PERSON bptjm-17 181 2 loong GPE bptjm-17 181 3 2018 DATE bptjm-17 181 4 ni et al. PERSON bptjm-17 181 5 2017 CARDINAL bptjm-17 181 6 lee et al. PERSON bptjm-17 181 7 2006 DATE bptjm-17 182 1 88.9% PERCENT bptjm-17 182 2 wyatt et al. PERSON bptjm-17 182 3 2017 DATE bptjm-17 183 1 2019 DATE bptjm-17 185 1 braf PERSON bptjm-17 185 2 the ras/raf/mapk ORG bptjm-17 186 1 three CARDINAL bptjm-17 187 1 braf v600 LAW bptjm-17 187 2 128 CARDINAL bptjm-17 188 1 k507 NORP bptjm-17 189 1 dankner et al. PERSON bptjm-17 189 2 2018 DATE bptjm-17 191 1 mek ORG bptjm-17 191 2 pan-raf ORG bptjm-17 193 1 dankner et al. PERSON bptjm-17 193 2 2018 DATE bptjm-17 194 1 lin et al PERSON bptjm-17 194 2 chinese NORP bptjm-17 195 1 1.2% to 4.2% PERCENT bptjm-17 195 2 chinese NORP bptjm-17 196 1 only 30% PERCENT bptjm-17 197 1 lin et al PERSON bptjm-17 198 1 lin et al. PERSON bptjm-17 198 2 2019 DATE bptjm-17 199 1 one CARDINAL bptjm-17 199 2 96.2% PERCENT bptjm-17 199 3 mao et al. PERSON bptjm-17 199 4 2017 DATE bptjm-17 200 1 nf1 ORG bptjm-17 200 2 ras-gtp ORG bptjm-17 201 1 ras associated ORG bptjm-17 201 2 kras ORG bptjm-17 201 3 nras GPE bptjm-17 201 4 rras PERSON bptjm-17 201 5 rras2 PERSON bptjm-17 202 1 nf1 ORG bptjm-17 202 2 ras ORG bptjm-17 205 1 berkeley pharma tech journal ORG bptjm-17 205 2 129 CARDINAL bptjm-17 205 3 nf1 ORG bptjm-17 205 4 2014 DATE bptjm-17 206 1 nf1 ORG bptjm-17 206 2 tao et al. PERSON bptjm-17 206 3 2020 DATE bptjm-17 207 1 tki ORG bptjm-17 207 2 nf1 ORG bptjm-17 207 3 1 CARDINAL bptjm-17 207 4 1 2 CARDINAL bptjm-17 207 5 3 CARDINAL bptjm-17 207 6 4 CARDINAL bptjm-17 207 7 187 CARDINAL bptjm-17 207 8 310 CARDINAL bptjm-17 208 1 cpeb4 ORG bptjm-17 208 2 dusp6 FAC bptjm-17 208 3 grb2, mcm4 PERSON bptjm-17 208 4 mdm2 PERSON bptjm-17 208 5 nf1 ORG bptjm-17 208 6 poldip2 GPE bptjm-17 208 7 stat2 ORG bptjm-17 209 1 66 years DATE bptjm-17 211 1 nf1 ORG bptjm-17 211 2 mdm2 PERSON bptjm-17 212 1 nf1 ORG bptjm-17 212 2 0.16 CARDINAL bptjm-17 212 3 ci PERSON bptjm-17 212 4 0.14 to 0.88 CARDINAL bptjm-17 212 5 0.0255 CARDINAL bptjm-17 213 1 the pi3k/akt ORG bptjm-17 215 1 akt GPE bptjm-17 216 1 sawa et al. PERSON bptjm-17 217 1 197 CARDINAL bptjm-17 218 1 10.4% PERCENT bptjm-17 218 2 1.7% PERCENT bptjm-17 218 3 0.015 CARDINAL bptjm-17 220 1 wang et al PERSON bptjm-17 220 2 95% PERCENT bptjm-17 220 3 0.58-1.12 MONEY bptjm-17 220 4 3 CARDINAL bptjm-17 221 1 berkeley pharma tech journal ORG bptjm-17 221 2 130 ros1 ros1 QUANTITY bptjm-17 226 1 egfr mutations PRODUCT bptjm-17 226 2 kras mutations PERSON bptjm-17 226 3 alk rearrangements PERSON bptjm-17 229 1 ihc ORG bptjm-17 229 2 luk et al. PERSON bptjm-17 229 3 2018 DATE bptjm-17 230 1 96.2% PERCENT bptjm-17 230 2 mao et al PERSON bptjm-17 230 3 2017 CARDINAL bptjm-17 231 1 128 CARDINAL bptjm-17 232 1 18 years DATE bptjm-17 232 2 alk PERSON bptjm-17 232 3 october 2015 DATE bptjm-17 232 4 august 2018 DATE bptjm-17 236 1 58.5 months DATE bptjm-17 236 2 95% PERCENT bptjm-17 236 3 26.9 CARDINAL bptjm-17 236 4 44.1 months DATE bptjm-17 236 5 non-alk PERSON bptjm-17 236 6 95% PERCENT bptjm-17 236 7 21.7 CARDINAL bptjm-17 236 8 105 months DATE bptjm-17 236 9 .001 CARDINAL bptjm-17 237 1 26.9 months DATE bptjm-17 237 2 95% PERCENT bptjm-17 237 3 13.9 months DATE bptjm-17 237 4 95% PERCENT bptjm-17 237 5 57.0 months DATE bptjm-17 237 6 .003 CARDINAL bptjm-17 238 1 20.7 months DATE bptjm-17 238 2 95% PERCENT bptjm-17 238 3 6.3 CARDINAL bptjm-17 238 4 2.8 months DATE bptjm-17 238 5 95% PERCENT bptjm-17 238 6 1.2 CARDINAL bptjm-17 238 7 one CARDINAL bptjm-17 239 1 berkeley pharma tech journal ORG bptjm-17 239 2 131 CARDINAL bptjm-17 239 3 alk alk PERSON bptjm-17 239 4 about 3-5% CARDINAL bptjm-17 240 1 55 years old DATE bptjm-17 241 1 ihc PERSON bptjm-17 243 1 kras ORG bptjm-17 244 1 kras PERSON bptjm-17 247 1 2010 DATE bptjm-17 248 1 2011 DATE bptjm-17 248 2 fda ORG bptjm-17 249 1 alk PERSON bptjm-17 250 1 vincent et al PERSON bptjm-17 250 2 2012 DATE bptjm-17 250 3 the past couple years DATE bptjm-17 251 1 ihc ORG bptjm-17 251 2 shaw et al. PERSON bptjm-17 251 3 2011 DATE bptjm-17 252 1 3 CARDINAL bptjm-17 254 1 al. ORG bptjm-17 254 2 2018 DATE bptjm-17 255 1 eml4-alk v2 TIME bptjm-17 257 1 madsen et al. PERSON bptjm-17 259 1 berkeley pharma tech journal ORG bptjm-17 259 2 132 CARDINAL bptjm-17 260 1 madsen et al. PERSON bptjm-17 260 2 2020 DATE bptjm-17 261 1 kras kirsten PERSON bptjm-17 261 2 liu et al. PERSON bptjm-17 261 3 2020 DATE bptjm-17 262 1 the k-ras ORG bptjm-17 264 1 kras ORG bptjm-17 264 2 g12c ORG bptjm-17 267 1 0.021 CARDINAL bptjm-17 267 2 2019 DATE bptjm-17 268 1 kras ORG bptjm-17 268 2 kras g12c ORG bptjm-17 269 1 100% PERCENT bptjm-17 269 2 kras g12c ORG bptjm-17 270 1 2020 DATE bptjm-17 271 1 kras g12c PERSON bptjm-17 271 2 wildtype kras ORG bptjm-17 271 3 kras ORG bptjm-17 271 4 0.74 CARDINAL bptjm-17 271 5 cui et al. PERSON bptjm-17 271 6 2020 DATE bptjm-17 272 1 vincent et al PERSON bptjm-17 273 1 2012 DATE bptjm-17 275 1 36 CARDINAL bptjm-17 275 2 18.6% PERCENT bptjm-17 275 3 194 CARDINAL bptjm-17 275 4 kras g12c ORG bptjm-17 276 1 17% PERCENT bptjm-17 278 1 mtorc1 PERSON bptjm-17 278 2 1 CARDINAL bptjm-17 279 1 hamartin PERSON bptjm-17 279 2 tsc1 PERSON bptjm-17 279 3 berkeley pharma tech journal ORG bptjm-17 279 4 133 CARDINAL bptjm-17 280 1 mtorc1 PERSON bptjm-17 281 1 hamartin ORG bptjm-17 281 2 two CARDINAL bptjm-17 281 3 sclc PERSON bptjm-17 282 1 166 CARDINAL bptjm-17 282 2 sclc ORG bptjm-17 283 1 greater than 50% PERCENT bptjm-17 283 2 al. GPE bptjm-17 283 3 2014 DATE bptjm-17 284 1 fuchs et al. PERSON bptjm-17 284 2 tsc LOC bptjm-17 286 1 wang et al PERSON bptjm-17 286 2 144 CARDINAL bptjm-17 286 3 tsc1 PERSON bptjm-17 286 4 tsc2 ORG bptjm-17 287 1 27 CARDINAL bptjm-17 287 2 144 CARDINAL bptjm-17 287 3 40 CARDINAL bptjm-17 287 4 tsc2 ORG bptjm-17 288 1 tsc ORG bptjm-17 289 1 sclc GPE bptjm-17 289 2 53.7% PERCENT bptjm-17 289 3 43.6% PERCENT bptjm-17 290 1 wang et al. PERSON bptjm-17 290 2 2020 DATE bptjm-17 291 1 tsc1 PERSON bptjm-17 291 2 14.1 months DATE bptjm-17 291 3 tsc2 ORG bptjm-17 291 4 110.6 months DATE bptjm-17 291 5 0.201 CARDINAL bptjm-17 292 1 wang et al PERSON bptjm-17 294 1 52% PERCENT bptjm-17 294 2 tsc1 PERSON bptjm-17 294 3 2020 DATE bptjm-17 295 1 tsc ORG bptjm-17 296 1 liu et al. PERSON bptjm-17 296 2 2018 DATE bptjm-17 297 1 1 CARDINAL bptjm-17 297 2 2 CARDINAL bptjm-17 298 1 fgfr1 ORG bptjm-17 298 2 fgfr2 ORG bptjm-17 299 1 berkeley pharma tech journal ORG bptjm-17 299 2 134 CARDINAL bptjm-17 299 3 2016 DATE bptjm-17 300 1 653 CARDINAL bptjm-17 301 1 fgfr1 GPE bptjm-17 301 2 fgfr2 ORG bptjm-17 302 1 fgfr1 DATE bptjm-17 302 2 0.02 CARDINAL bptjm-17 302 3 fgfr2 ORG bptjm-17 302 4 0.27 CARDINAL bptjm-17 302 5 fgfr2 ORG bptjm-17 302 6 0.002 CARDINAL bptjm-17 303 1 fgfr1 DATE bptjm-17 303 2 10.6% PERCENT bptjm-17 303 3 fgfr2 ORG bptjm-17 303 4 12.9% PERCENT bptjm-17 303 5 2016 DATE bptjm-17 305 1 fgfr1 ORG bptjm-17 305 2 fgfr2 ORG bptjm-17 305 3 age 31 to 53 years DATE bptjm-17 307 1 santiago-walker et al. ORG bptjm-17 307 2 63% PERCENT bptjm-17 309 1 2019 DATE bptjm-17 310 1 fgfr1 ORG bptjm-17 310 2 2016 DATE bptjm-17 311 1 10-35% PERCENT bptjm-17 313 1 about 30% PERCENT bptjm-17 314 1 502 CARDINAL bptjm-17 314 2 between 2003 and 2014 DATE bptjm-17 316 1 35-55% PERCENT bptjm-17 317 1 502 CARDINAL bptjm-17 318 1 mutant tp53 ORG bptjm-17 318 2 42.2 months DATE bptjm-17 318 3 37.7 months DATE bptjm-17 319 1 60 CARDINAL bptjm-17 320 1 60 CARDINAL bptjm-17 320 2 24 CARDINAL bptjm-17 320 3 36 CARDINAL bptjm-17 320 4 wildtype tp53 ORG bptjm-17 321 1 berkeley pharma tech journal ORG bptjm-17 321 2 135 CARDINAL bptjm-17 321 3 al. PERSON bptjm-17 321 4 2017 DATE bptjm-17 324 1 60 CARDINAL bptjm-17 324 2 rrm1 PERSON bptjm-17 326 1 rrm1 PERSON bptjm-17 326 2 al. PERSON bptjm-17 326 3 2018 DATE bptjm-17 327 1 zhang et al. PERSON bptjm-17 327 2 rrm1 PERSON bptjm-17 327 3 ercc1 PERSON bptjm-17 329 1 18.5 months DATE bptjm-17 329 2 13.0 months DATE bptjm-17 329 3 0.043 CARDINAL bptjm-17 330 1 rrm1 PERSON bptjm-17 331 1 6.0 months DATE bptjm-17 331 2 4.0 months DATE bptjm-17 331 3 zhang et al. PERSON bptjm-17 331 4 2012 DATE bptjm-17 333 1 wip1 PERSON bptjm-17 333 2 1 CARDINAL bptjm-17 333 3 wip1 GPE bptjm-17 334 1 zhao et al. PERSON bptjm-17 334 2 117 CARDINAL bptjm-17 334 3 wip1 PERSON bptjm-17 334 4 ihc ORG bptjm-17 335 1 87 CARDINAL bptjm-17 335 2 30 CARDINAL bptjm-17 336 1 wip1 PERSON bptjm-17 336 2 wip1 PERSON bptjm-17 336 3 69.3% PERCENT bptjm-17 337 1 wip1 PERSON bptjm-17 338 1 wip1 GPE bptjm-17 339 1 80 months DATE bptjm-17 339 2 wip1 GPE bptjm-17 339 3 less than 20% PERCENT bptjm-17 339 4 wip1 GPE bptjm-17 339 5 over 40% PERCENT bptjm-17 339 6 zhao et al. PERSON bptjm-17 339 7 2016 DATE bptjm-17 340 1 84 CARDINAL bptjm-17 340 2 46 CARDINAL bptjm-17 340 3 38 CARDINAL bptjm-17 342 1 wip1 PERSON bptjm-17 342 2 ihc ORG bptjm-17 343 1 wip1 PERSON bptjm-17 343 2 10% PERCENT bptjm-17 343 3 wip1 GPE bptjm-17 343 4 ihc PERSON bptjm-17 344 1 wip1 PERSON bptjm-17 344 2 berkeley pharma tech journal ORG bptjm-17 344 3 136 64.3% PERCENT bptjm-17 345 1 wip1 GPE bptjm-17 345 2 wip1 GPE bptjm-17 346 1 around 50% PERCENT bptjm-17 346 2 wip1 GPE bptjm-17 346 3 100 months DATE bptjm-17 346 4 around 90% PERCENT bptjm-17 346 5 wip1 GPE bptjm-17 347 1 wip1 PERSON bptjm-17 347 2 satoh et al. PERSON bptjm-17 347 3 2011 DATE bptjm-17 348 1 wip1 PERSON bptjm-17 349 1 mirna PERSON bptjm-17 349 2 3 CARDINAL bptjm-17 350 1 mirna PERSON bptjm-17 351 1 3a CARDINAL bptjm-17 351 2 mirna PERSON bptjm-17 351 3 mirna PERSON bptjm-17 351 4 pri-mirna PERSON bptjm-17 352 1 3b CARDINAL bptjm-17 352 2 3c CARDINAL bptjm-17 352 3 pri-mirna ORG bptjm-17 352 4 mirna PERSON bptjm-17 353 1 3d CARDINAL bptjm-17 355 1 3e CARDINAL bptjm-17 355 2 mirna PERSON bptjm-17 355 3 mirna PERSON bptjm-17 356 1 3f CARDINAL bptjm-17 357 1 mirna PERSON bptjm-17 357 2 2010 DATE bptjm-17 358 1 mir FAC bptjm-17 359 1 2019 DATE bptjm-17 360 1 xie et al. PERSON bptjm-17 361 1 19 CARDINAL bptjm-17 361 2 2016 DATE bptjm-17 362 1 berkeley pharma tech journal ORG bptjm-17 362 2 137 CARDINAL bptjm-17 362 3 3p CARDINAL bptjm-17 363 1 zhu et al. PERSON bptjm-17 363 2 2014 DATE bptjm-17 364 1 2014 DATE bptjm-17 364 2 245 CARDINAL bptjm-17 365 1 120 CARDINAL bptjm-17 365 2 360 CARDINAL bptjm-17 367 1 96 CARDINAL bptjm-17 367 2 dou et al. PERSON bptjm-17 367 3 2015 DATE bptjm-17 368 1 mir-21 mir-21 TIME bptjm-17 368 2 oncogenic mirna PERSON bptjm-17 368 3 feng et al. PERSON bptjm-17 368 4 2016 DATE bptjm-17 368 5 mir-21 DATE bptjm-17 369 1 wang et al PERSON bptjm-17 369 2 88 CARDINAL bptjm-17 369 3 17 CARDINAL bptjm-17 369 4 jiangsu province GPE bptjm-17 370 1 3-year DATE bptjm-17 370 2 serummir-21 DATE bptjm-17 370 3 39.8% PERCENT bptjm-17 370 4 58.2% PERCENT bptjm-17 370 5 serummir-21 DATE bptjm-17 370 6 wang et al. PERSON bptjm-17 370 7 2011 DATE bptjm-17 371 1 liu et al PERSON bptjm-17 371 2 mir-21 DATE bptjm-17 371 3 mir-21 DATE bptjm-17 371 4 2012 DATE bptjm-17 372 1 mir-21 DATE bptjm-17 373 1 mirna PERSON bptjm-17 373 2 2011 DATE bptjm-17 374 1 mir-21 DATE bptjm-17 374 2 195 CARDINAL bptjm-17 374 3 30 CARDINAL bptjm-17 374 4 mir-21 DATE bptjm-17 374 5 2017 DATE bptjm-17 375 1 berkeley pharma tech journal ORG bptjm-17 375 2 138 CARDINAL bptjm-17 375 3 han-bo le PERSON bptjm-17 375 4 mir-21 DATE bptjm-17 375 5 mir-21 DATE bptjm-17 377 1 wei j et al PERSON bptjm-17 377 2 53 CARDINAL bptjm-17 378 1 mir-21 DATE bptjm-17 378 2 wei et al. PERSON bptjm-17 378 3 2011 DATE bptjm-17 379 1 gao et al PERSON bptjm-17 379 2 58 CARDINAL bptjm-17 379 3 mir-21 DATE bptjm-17 379 4 gao et al. PERSON bptjm-17 379 5 2012 DATE bptjm-17 380 1 mir-30 GPE bptjm-17 380 2 mir-30 GPE bptjm-17 381 1 mir-30 GPE bptjm-17 381 2 mao et al. PERSON bptjm-17 381 3 2018 DATE bptjm-17 382 1 mir-30b DATE bptjm-17 383 1 29 CARDINAL bptjm-17 383 2 mir-30b DATE bptjm-17 383 3 pfs PERSON bptjm-17 384 1 mir-30b DATE bptjm-17 384 2 2019 DATE bptjm-17 385 1 104 CARDINAL bptjm-17 385 2 20 CARDINAL bptjm-17 385 3 west china LOC bptjm-17 385 4 mir-30a-5p PERSON bptjm-17 387 1 mir-30a-5p PERSON bptjm-17 387 2 liang et al. PERSON bptjm-17 387 3 2019 DATE bptjm-17 388 1 kaplan PERSON bptjm-17 388 2 mir-30a-5p PERSON bptjm-17 389 1 kaplan PERSON bptjm-17 389 2 meier survival PERSON bptjm-17 389 3 berkeley pharma tech journal ORG bptjm-17 389 4 139 CARDINAL bptjm-17 389 5 2010 DATE bptjm-17 390 1 mir-30a-5p PERSON bptjm-17 390 2 mir-30a-5p ORG bptjm-17 390 3 liang et al. PERSON bptjm-17 390 4 2019 DATE bptjm-17 395 1 cui et al PERSON bptjm-17 396 1 260 CARDINAL bptjm-17 396 2 260 CARDINAL bptjm-17 397 1 99 CARDINAL bptjm-17 397 2 38% PERCENT bptjm-17 397 3 161 CARDINAL bptjm-17 397 4 62% PERCENT bptjm-17 400 1 shi et al PERSON bptjm-17 400 2 74 CARDINAL bptjm-17 400 3 2020 DATE bptjm-17 402 1 yuxia et al PERSON bptjm-17 403 1 193 CARDINAL bptjm-17 404 1 2.79 CARDINAL bptjm-17 405 1 kaplan-meier ORG bptjm-17 405 2 00001 DATE bptjm-17 406 1 yuxia et al. PERSON bptjm-17 406 2 2012 DATE bptjm-17 407 1 berkeley pharma tech journal ORG bptjm-17 407 2 140 CARDINAL bptjm-17 407 3 liu et al. PERSON bptjm-17 407 4 2018 DATE bptjm-17 408 1 mir-145 PERSON bptjm-17 409 1 345 CARDINAL bptjm-17 409 2 5 CARDINAL bptjm-17 409 3 mirna PERSON bptjm-17 409 4 mir-28 ORG bptjm-17 409 5 3p CARDINAL bptjm-17 410 1 80% PERCENT bptjm-17 411 1 5 CARDINAL bptjm-17 411 2 3.6 to 5.7 months DATE bptjm-17 414 1 88.4% PERCENT bptjm-17 414 2 3 year DATE bptjm-17 414 3 79.2% PERCENT bptjm-17 414 4 3 year DATE bptjm-17 414 5 5.21e−03 CARDINAL bptjm-17 415 1 mir-145 PERSON bptjm-17 415 2 ras ORG bptjm-17 415 3 zhang et al. PERSON bptjm-17 415 4 2019 DATE bptjm-17 420 1 180 CARDINAL bptjm-17 420 2 80 CARDINAL bptjm-17 420 3 mir-21 DATE bptjm-17 420 4 one CARDINAL bptjm-17 420 5 68 CARDINAL bptjm-17 420 6 112 CARDINAL bptjm-17 421 1 0.01 CARDINAL bptjm-17 421 2 0.05 CARDINAL bptjm-17 421 3 mir-21 DATE bptjm-17 421 4 0.01 CARDINAL bptjm-17 422 1 91.96% PERCENT bptjm-17 422 2 19 month DATE bptjm-17 422 3 berkeley pharma tech journal ORG bptjm-17 422 4 141 CARDINAL bptjm-17 422 5 57.35% PERCENT bptjm-17 422 6 28 month DATE bptjm-17 422 7 0.05 CARDINAL bptjm-17 422 8 xu et al. PERSON bptjm-17 422 9 2019 DATE bptjm-17 423 1 three-mirna QUANTITY bptjm-17 423 2 mir-155-5p CARDINAL bptjm-17 423 3 3p CARDINAL bptjm-17 423 4 46 months DATE bptjm-17 423 5 52 CARDINAL bptjm-17 423 6 2013 DATE bptjm-17 424 1 three CARDINAL bptjm-17 424 2 maryland GPE bptjm-17 424 3 norway GPE bptjm-17 424 4 japan GPE bptjm-17 424 5 mir-17 ORG bptjm-17 424 6 mir-21 DATE bptjm-17 424 7 dfs ORG bptjm-17 424 8 saito et al. PERSON bptjm-17 424 9 2011 DATE bptjm-17 426 1 335 CARDINAL bptjm-17 428 1 84 months DATE bptjm-17 428 2 190 months DATE bptjm-17 429 1 al. GPE bptjm-17 429 2 2011 DATE bptjm-17 430 1 hana et al PERSON bptjm-17 430 2 52 CARDINAL bptjm-17 430 3 69 days DATE bptjm-17 430 4 58 days DATE bptjm-17 430 5 hana et al. PERSON bptjm-17 430 6 2020 DATE bptjm-17 432 1 sromek et al PERSON bptjm-17 432 2 one year DATE bptjm-17 432 3 2017 DATE bptjm-17 433 1 jiang et al PERSON bptjm-17 434 1 7 CARDINAL bptjm-17 434 2 jiang et al. PERSON bptjm-17 434 3 2018 DATE bptjm-17 435 1 3 CARDINAL bptjm-17 436 1 gao et al PERSON bptjm-17 437 1 140 CARDINAL bptjm-17 437 2 gao et al. PERSON bptjm-17 437 3 2020 DATE bptjm-17 438 1 berkeley pharma tech journal ORG bptjm-17 438 2 142 CARDINAL bptjm-17 438 3 mir-30d DATE bptjm-17 438 4 4 CARDINAL bptjm-17 439 1 60 CARDINAL bptjm-17 439 2 two CARDINAL bptjm-17 439 3 0.001 CARDINAL bptjm-17 439 4 one CARDINAL bptjm-17 439 5 mirna PERSON bptjm-17 439 6 hu et al. PERSON bptjm-17 439 7 2010 DATE bptjm-17 440 1 un ORG bptjm-17 441 1 un ORG bptjm-17 441 2 19 months DATE bptjm-17 441 3 li et al. PERSON bptjm-17 441 4 2015 DATE bptjm-17 442 1 5p CARDINAL bptjm-17 443 1 one CARDINAL bptjm-17 443 2 5p CARDINAL bptjm-17 443 3 arhgap5 PERSON bptjm-17 444 1 5p CARDINAL bptjm-17 444 2 arhgap5 PERSON bptjm-17 445 1 wang et al. PERSON bptjm-17 445 2 2014 DATE bptjm-17 446 1 5p CARDINAL bptjm-17 447 1 5p CARDINAL bptjm-17 447 2 48 hours TIME bptjm-17 447 3 0.05 CARDINAL bptjm-17 447 4 72 hours TIME bptjm-17 447 5 0.05 CARDINAL bptjm-17 447 6 5p CARDINAL bptjm-17 447 7 0.001 CARDINAL bptjm-17 447 8 tian NORP bptjm-17 447 9 2019 DATE bptjm-17 448 1 5p CARDINAL bptjm-17 449 1 5p CARDINAL bptjm-17 449 2 5p CARDINAL bptjm-17 449 3 lin actin PERSON bptjm-17 449 4 1 CARDINAL bptjm-17 450 1 5p CARDINAL bptjm-17 450 2 0.001 CARDINAL bptjm-17 450 3 jin et al. PERSON bptjm-17 450 4 2019 DATE bptjm-17 452 1 first ORDINAL bptjm-17 452 2 berkeley pharma tech journal ORG bptjm-17 452 3 143 CARDINAL bptjm-17 454 1 second ORDINAL bptjm-17 458 1 veri ed PERSON bptjm-17 461 1 brca ORG bptjm-17 464 1 96.2% PERCENT bptjm-17 464 2 ret ORG bptjm-17 464 3 81.6% PERCENT bptjm-17 466 1 mirna PERSON bptjm-17 467 1 mirna PERSON bptjm-17 471 1 berkeley pharma tech journal ORG bptjm-17 471 2 144 CARDINAL bptjm-17 473 1 mirna PERSON bptjm-17 474 1 mirna PERSON bptjm-17 475 1 berkeley pharma tech journal ORG bptjm-17 475 2 145 CARDINAL bptjm-17 475 3 1 CARDINAL bptjm-17 475 4 aredo PERSON bptjm-17 475 5 j. v. PERSON bptjm-17 475 6 s. k. PERSON bptjm-17 475 7 kunder PERSON bptjm-17 475 8 c. a. PERSON bptjm-17 475 9 han NORP bptjm-17 475 10 s. s. PERSON bptjm-17 475 11 neal PERSON bptjm-17 475 12 j. w. PERSON bptjm-17 475 13 j. b. PERSON bptjm-17 475 14 h. a. PERSON bptjm-17 475 15 2019 DATE bptjm-17 476 1 kras ORG bptjm-17 477 1 amsterdam GPE bptjm-17 477 2 netherlands GPE bptjm-17 477 3 133 CARDINAL bptjm-17 477 4 144–150 CARDINAL bptjm-17 478 1 2 CARDINAL bptjm-17 478 2 a. GPE bptjm-17 478 3 corso, s. ORG bptjm-17 478 4 a. PERSON bptjm-17 478 5 hobor GPE bptjm-17 478 6 s. GPE bptjm-17 478 7 valtorta GPE bptjm-17 478 8 e., siravegna ORG bptjm-17 478 9 sartore bianchi PERSON bptjm-17 478 10 a. GPE bptjm-17 478 11 scala GPE bptjm-17 478 12 a. PERSON bptjm-17 478 13 zecchin ORG bptjm-17 478 14 d. NORP bptjm-17 478 15 m., migliardi PERSON bptjm-17 478 16 f. PERSON bptjm-17 478 17 lauricella PERSON bptjm-17 478 18 perera GPE bptjm-17 478 19 t. GPE bptjm-17 478 20 veronese NORP bptjm-17 478 21 s. PERSON bptjm-17 478 22 g., amatu, a. PERSON bptjm-17 478 23 gambacorta GPE bptjm-17 478 24 m. PERSON bptjm-17 478 25 siena GPE bptjm-17 478 26 s. GPE bptjm-17 478 27 2013 DATE bptjm-17 480 1 3(6 CARDINAL bptjm-17 480 2 658–673 CARDINAL bptjm-17 481 1 10.1158/2159-8290.cd-12-0558 3 DATE bptjm-17 481 2 beauchamp ORG bptjm-17 481 3 e. m. PERSON bptjm-17 481 4 b. a. PERSON bptjm-17 481 5 dulak GPE bptjm-17 481 6 a. m. PERSON bptjm-17 481 7 l. PERSON bptjm-17 481 8 xu PERSON bptjm-17 481 9 n. s. PERSON bptjm-17 481 10 a. j. PERSON bptjm-17 481 11 wong PERSON bptjm-17 481 12 k. k. PERSON bptjm-17 481 13 meyerson GPE bptjm-17 481 14 m., & hammerman ORG bptjm-17 481 15 p. s. PERSON bptjm-17 481 16 2014 DATE bptjm-17 482 1 nf1 ORG bptjm-17 483 1 13(2 CARDINAL bptjm-17 483 2 475–482 CARDINAL bptjm-17 484 1 4 CARDINAL bptjm-17 484 2 bettegowda PERSON bptjm-17 484 3 m. GPE bptjm-17 484 4 leary GPE bptjm-17 484 5 r. j. PERSON bptjm-17 484 6 kinde GPE bptjm-17 484 7 i. PERSON bptjm-17 484 8 wang PERSON bptjm-17 484 9 agrawal, n. PERSON bptjm-17 484 10 bartlett PERSON bptjm-17 484 11 b. r. PERSON bptjm-17 484 12 wang, h. ORG bptjm-17 484 13 alani NORP bptjm-17 484 14 r. m. PERSON bptjm-17 484 15 antonarakis PERSON bptjm-17 484 16 e. s. PERSON bptjm-17 484 17 azad GPE bptjm-17 484 18 n. s. PERSON bptjm-17 484 19 a. GPE bptjm-17 484 20 brem, h., cameron ORG bptjm-17 484 21 j. l. PERSON bptjm-17 484 22 lee PERSON bptjm-17 484 23 c. c. PERSON bptjm-17 484 24 l. a. PERSON bptjm-17 484 25 gallia GPE bptjm-17 484 26 g. l. PERSON bptjm-17 484 27 gibbs PERSON bptjm-17 485 1 l. a. PERSON bptjm-17 485 2 2014 DATE bptjm-17 487 1 6(224 CARDINAL bptjm-17 487 2 224ra24 TIME bptjm-17 488 1 https://doi.org/10.1126/ ORG bptjm-17 488 2 5 CARDINAL bptjm-17 489 1 schwich PERSON bptjm-17 489 2 e., jensen PERSON bptjm-17 489 3 p. a. PERSON bptjm-17 489 4 kimmig GPE bptjm-17 489 5 r. NORP bptjm-17 489 6 kasimir-bauer PERSON bptjm-17 489 7 s., & rebmann ORG bptjm-17 489 8 2019 CARDINAL bptjm-17 490 1 ligands spd-l1 PERSON bptjm-17 491 1 9 CARDINAL bptjm-17 491 2 1015 DATE bptjm-17 492 1 d. r. PERSON bptjm-17 492 2 s. a. PERSON bptjm-17 492 3 flacco, a. ORG bptjm-17 492 4 tan, PERSON bptjm-17 492 5 a. c. PERSON bptjm-17 492 6 r. c. PERSON bptjm-17 492 7 zhou GPE bptjm-17 492 8 q. PERSON bptjm-17 492 9 franklin ORG bptjm-17 492 10 w. a. PERSON bptjm-17 492 11 2010 DATE bptjm-17 494 1 the american association ORG bptjm-17 494 2 5581–5590 CARDINAL bptjm-17 495 1 10.1158/1078-0432.ccr-10-0851 7 CARDINAL bptjm-17 496 1 chae PERSON bptjm-17 496 2 y. k. PERSON bptjm-17 496 3 andrew a. d. PERSON bptjm-17 496 4 j., cesar PERSON bptjm-17 496 5 s.m. GPE bptjm-17 496 6 lisa, f., PERSON bptjm-17 496 7 nike GPE bptjm-17 496 8 b. GPE bptjm-17 496 9 leonidas, c. p. GPE bptjm-17 496 10 william, g. PERSON bptjm-17 496 11 francis j. g. PERSON bptjm-17 496 12 massimo ORG bptjm-17 496 13 2017 CARDINAL bptjm-17 498 1 16(7 CARDINAL bptjm-17 498 2 1412–1420 CARDINAL bptjm-17 500 1 chian ORG bptjm-17 500 2 c. f., hwang PERSON bptjm-17 500 3 h. j. PERSON bptjm-17 500 4 lee PERSON bptjm-17 500 5 s. c. PERSON bptjm-17 500 6 chao PERSON bptjm-17 500 7 t. y. PERSON bptjm-17 500 8 chang, h. ORG bptjm-17 500 9 ho PERSON bptjm-17 500 10 c. l. PERSON bptjm-17 500 11 wu PERSON bptjm-17 500 12 w. c. PERSON bptjm-17 500 13 2016 DATE bptjm-17 502 1 7(31 CARDINAL bptjm-17 502 2 50582–50595 CARDINAL bptjm-17 502 3 9 CARDINAL bptjm-17 502 4 chirshev PERSON bptjm-17 502 5 e. GPE bptjm-17 502 6 oberg PERSON bptjm-17 502 7 k. c. PERSON bptjm-17 502 8 io LOC bptjm-17 502 9 j., & ORG bptjm-17 502 10 j. j. PERSON bptjm-17 502 11 2019 DATE bptjm-17 503 1 7 CARDINAL bptjm-17 504 1 8(1 CARDINAL bptjm-17 505 1 10 CARDINAL bptjm-17 506 1 christopoulos PERSON bptjm-17 506 2 kirchner PERSON bptjm-17 506 3 m. PERSON bptjm-17 506 4 endris GPE bptjm-17 506 5 a., & thomas ORG bptjm-17 506 6 2018 DATE bptjm-17 508 1 10(suppl 17 DATE bptjm-17 509 1 berkeley pharma tech journal ORG bptjm-17 509 2 146 CARDINAL bptjm-17 510 1 chuang PERSON bptjm-17 510 2 j. c. PERSON bptjm-17 510 3 s. PERSON bptjm-17 510 4 ying PERSON bptjm-17 510 5 d. NORP bptjm-17 510 6 jane, h. PERSON bptjm-17 510 7 maximilian PERSON bptjm-17 510 8 d. NORP bptjm-17 510 9 a. w. PERSON bptjm-17 510 10 joel PERSON bptjm-17 510 11 w. n. ( PERSON bptjm-17 510 12 2017 CARDINAL bptjm-17 512 1 12(5 CARDINAL bptjm-17 512 2 833–842 CARDINAL bptjm-17 514 1 12 CARDINAL bptjm-17 514 2 cui PERSON bptjm-17 514 3 e. h. PERSON bptjm-17 514 4 li PERSON bptjm-17 514 5 h. j. PERSON bptjm-17 514 6 wang PERSON bptjm-17 514 7 b. PERSON bptjm-17 514 8 mao PERSON bptjm-17 514 9 w. PERSON bptjm-17 514 10 feng PERSON bptjm-17 514 11 x. r. PERSON bptjm-17 514 12 2013 DATE bptjm-17 515 1 microrna 125b CARDINAL bptjm-17 518 1 34 CARDINAL bptjm-17 518 2 2 CARDINAL bptjm-17 518 3 309–313 CARDINAL bptjm-17 519 1 10.1038 CARDINAL bptjm-17 519 2 13 CARDINAL bptjm-17 520 1 dacic ORG bptjm-17 520 2 hannelore kothmaier PERSON bptjm-17 520 3 stephanie land ORG bptjm-17 520 4 yongli shuai PERSON bptjm-17 520 5 patrizia morbini ORG bptjm-17 520 6 bruno murer PERSON bptjm-17 521 1 archiv 453 ORG bptjm-17 521 2 6 CARDINAL bptjm-17 521 3 december 1, 2008 DATE bptjm-17 521 4 627–35 DATE bptjm-17 523 1 14 DATE bptjm-17 524 1 dankner PERSON bptjm-17 524 2 m. PERSON bptjm-17 524 3 a. PERSON bptjm-17 524 4 rajkumar GPE bptjm-17 524 5 s., siegel PERSON bptjm-17 524 6 m., & watson ORG bptjm-17 524 7 i. r. PERSON bptjm-17 524 8 2018 DATE bptjm-17 526 1 3183–3199 CARDINAL bptjm-17 527 1 15 CARDINAL bptjm-17 527 2 de marco PERSON bptjm-17 527 3 c. PERSON bptjm-17 527 4 c., rinaldo PERSON bptjm-17 527 5 n. PERSON bptjm-17 527 6 oliveira GPE bptjm-17 527 7 d. m. PERSON bptjm-17 527 8 ravo PERSON bptjm-17 527 9 m., weisz, a. PERSON bptjm-17 527 10 ceccarelli PERSON bptjm-17 527 11 m. PERSON bptjm-17 527 12 caira PERSON bptjm-17 527 13 e. GPE bptjm-17 527 14 rizzuto, a. ORG bptjm-17 527 15 malanga GPE bptjm-17 527 16 d., & viglietto ORG bptjm-17 527 17 2017 CARDINAL bptjm-17 529 1 plos one PERSON bptjm-17 529 2 12(6 CARDINAL bptjm-17 530 1 16 CARDINAL bptjm-17 531 1 delmonico ORG bptjm-17 531 2 l. et al PERSON bptjm-17 532 1 2019 DATE bptjm-17 533 1 tp53 ORG bptjm-17 534 1 39 CARDINAL bptjm-17 534 2 30–35 CARDINAL bptjm-17 536 1 17 CARDINAL bptjm-17 537 1 gagliato d. de melo ORG bptjm-17 537 2 jardim d. leonardo fontes PERSON bptjm-17 537 3 marchesi m. sergio pereira PERSON bptjm-17 537 4 hortobagyi g. n. PERSON bptjm-17 537 5 2016 DATE bptjm-17 540 1 7 CARDINAL bptjm-17 540 2 64431-64446 DATE bptjm-17 541 1 18. DATE bptjm-17 542 1 h. PERSON bptjm-17 542 2 kanaoka PERSON bptjm-17 542 3 r. NORP bptjm-17 542 4 n., & kawamura ORG bptjm-17 542 5 m. ( PERSON bptjm-17 542 6 2017 CARDINAL bptjm-17 543 1 exosomal microrna PERSON bptjm-17 544 1 13(3 CARDINAL bptjm-17 544 2 1256–1263 CARDINAL bptjm-17 545 1 https://doi.org/10.3892/ol.2017.5569 19 DATE bptjm-17 545 2 deng, l. PERSON bptjm-17 545 3 kiedrowski PERSON bptjm-17 545 4 l. a. PERSON bptjm-17 545 5 ravera GPE bptjm-17 545 6 e. GPE bptjm-17 545 7 cheng PERSON bptjm-17 545 8 2018 DATE bptjm-17 547 1 the international association for the study of lung cancer ORG bptjm-17 548 1 20 CARDINAL bptjm-17 549 1 t., GPE bptjm-17 549 2 k. PERSON bptjm-17 549 3 berg PERSON bptjm-17 549 4 t. et al PERSON bptjm-17 550 1 2011 DATE bptjm-17 552 1 9(6 CARDINAL bptjm-17 553 1 https://doi.org/10.1186/1479-5876-9-6 PERSON bptjm-17 555 1 dou, h. ORG bptjm-17 555 2 wang PERSON bptjm-17 555 3 su PERSON bptjm-17 555 4 s. PERSON bptjm-17 555 5 2015 CARDINAL bptjm-17 557 1 8(6 CARDINAL bptjm-17 557 2 9291–9298 CARDINAL bptjm-17 558 1 22 CARDINAL bptjm-17 560 1 n.d. GPE bptjm-17 562 1 december 08, 2020 DATE bptjm-17 562 2 berkeley pharma tech journal ORG bptjm-17 562 3 147 CARDINAL bptjm-17 562 4 23 CARDINAL bptjm-17 563 1 a. f., le PERSON bptjm-17 563 2 l. p. PERSON bptjm-17 563 3 zheng PERSON bptjm-17 563 4 z. PERSON bptjm-17 563 5 a. PERSON bptjm-17 563 6 patel PERSON bptjm-17 563 7 t. m. PERSON bptjm-17 563 8 liu PERSON bptjm-17 563 9 s. v. PERSON bptjm-17 563 10 s. h. PERSON bptjm-17 563 11 jackman PERSON bptjm-17 563 12 d. NORP bptjm-17 563 13 costa GPE bptjm-17 563 14 d. b. PERSON bptjm-17 563 15 p. s. PERSON bptjm-17 563 16 li PERSON bptjm-17 563 17 g. g. PERSON bptjm-17 563 18 hornby GPE bptjm-17 563 19 z. PERSON bptjm-17 563 20 luo PERSON bptjm-17 563 21 d. NORP bptjm-17 563 22 lim PERSON bptjm-17 563 23 j. e. PERSON bptjm-17 563 24 iafrate ORG bptjm-17 563 25 a. j., & shaw PERSON bptjm-17 563 26 a. t. PERSON bptjm-17 563 27 2015 CARDINAL bptjm-17 565 1 the international association for the study of lung ORG bptjm-17 565 2 10(12 CARDINAL bptjm-17 565 3 1670–1674 DATE bptjm-17 567 1 0000473485.38553.f0. DATE bptjm-17 568 1 24 DATE bptjm-17 569 1 feng PERSON bptjm-17 569 2 y. h., & tsao ORG bptjm-17 569 3 c. j. PERSON bptjm-17 569 4 2016 DATE bptjm-17 570 1 microrna-21 DATE bptjm-17 571 1 5(4 CARDINAL bptjm-17 571 2 395–402 CARDINAL bptjm-17 574 1 fuchs ORG bptjm-17 574 2 a. PERSON bptjm-17 574 3 könig PERSON bptjm-17 574 4 k. PERSON bptjm-17 574 5 l. c. PERSON bptjm-17 574 6 j., kirfel PERSON bptjm-17 574 7 j., huss PERSON bptjm-17 574 8 s. GPE bptjm-17 574 9 becker PERSON bptjm-17 574 10 a. j. PERSON bptjm-17 574 11 r., & majores ORG bptjm-17 574 12 m. PERSON bptjm-17 574 13 2014 DATE bptjm-17 576 1 9(48 CARDINAL bptjm-17 577 1 https://doi.org/10.1186/1746-1596-9-48 26 DATE bptjm-17 578 1 friedmann CARDINAL bptjm-17 578 2 d., & verma ORG bptjm-17 578 3 i. m. PERSON bptjm-17 578 4 2014 DATE bptjm-17 580 1 15(3 CARDINAL bptjm-17 580 2 244–253 CARDINAL bptjm-17 581 1 https://doi.org/10.1002/ ORG bptjm-17 581 2 27 DATE bptjm-17 582 1 gao PERSON bptjm-17 582 2 w. PERSON bptjm-17 582 3 x. GPE bptjm-17 582 4 liu PERSON bptjm-17 582 5 xu PERSON bptjm-17 582 6 j. PERSON bptjm-17 582 7 feng GPE bptjm-17 582 8 2012 DATE bptjm-17 583 1 mirna-21 DATE bptjm-17 584 1 13(5 CARDINAL bptjm-17 584 2 330–340 CARDINAL bptjm-17 585 1 28 CARDINAL bptjm-17 586 1 gao PERSON bptjm-17 586 2 z.j. GPE bptjm-17 586 3 2020 DATE bptjm-17 588 1 9(1 CARDINAL bptjm-17 588 2 104–110 CARDINAL bptjm-17 589 1 m.d. GPE bptjm-17 589 2 gregg s.l. PERSON bptjm-17 589 3 denis w. PERSON bptjm-17 589 4 june 2014 DATE bptjm-17 591 1 14(6 DATE bptjm-17 591 2 430–39 DATE bptjm-17 593 1 29 CARDINAL bptjm-17 594 1 hamilton PERSON bptjm-17 594 2 2018 DATE bptjm-17 595 1 ercc1 PERSON bptjm-17 596 1 14(1 CARDINAL bptjm-17 596 2 17–24 DATE bptjm-17 597 1 30 CARDINAL bptjm-17 598 1 hana�, a. r. PERSON bptjm-17 598 2 a. m. PERSON bptjm-17 598 3 alfasunu PERSON bptjm-17 598 4 s. PERSON bptjm-17 598 5 a. h. PERSON bptjm-17 598 6 d. NORP bptjm-17 598 7 heriyanto GPE bptjm-17 598 8 d. s., & haryana ORG bptjm-17 598 9 s. m. PERSON bptjm-17 598 10 2020 DATE bptjm-17 599 1 serum mirna PERSON bptjm-17 599 2 indonesia GPE bptjm-17 600 1 zhongguo fei PERSON bptjm-17 600 2 za zhi PERSON bptjm-17 602 1 chinese NORP bptjm-17 602 2 23(5 CARDINAL bptjm-17 602 3 321–332 CARDINAL bptjm-17 604 1 1009-3419.2020.104.02 31 DATE bptjm-17 605 1 hojbjerg PERSON bptjm-17 605 2 j. a. PERSON bptjm-17 605 3 ebert PERSON bptjm-17 605 4 e. b. f. PERSON bptjm-17 605 5 clement PERSON bptjm-17 605 6 m. s. PERSON bptjm-17 605 7 winther-larsen PERSON bptjm-17 605 8 a. PERSON bptjm-17 605 9 meldgaard, p., & sorensen ORG bptjm-17 605 10 b. PERSON bptjm-17 605 11 2019 DATE bptjm-17 606 1 mir-30b DATE bptjm-17 607 1 135 CARDINAL bptjm-17 607 2 92–96 CARDINAL bptjm-17 608 1 32 CARDINAL bptjm-17 609 1 krapcho PERSON bptjm-17 609 2 m., mille PERSON bptjm-17 609 3 d. NORP bptjm-17 609 4 bresi, a. ORG bptjm-17 609 5 yu GPE bptjm-17 609 6 ruhl PERSON bptjm-17 609 7 j., tatalovich ORG bptjm-17 609 8 z. PERSON bptjm-17 609 9 a., lewis PERSON bptjm-17 609 10 d.r. GPE bptjm-17 609 11 chen PERSON bptjm-17 609 12 h.s. GPE bptjm-17 609 13 e.j. GPE bptjm-17 609 14 cronin PERSON bptjm-17 609 15 k.a. GPE bptjm-17 610 1 2017 CARDINAL bptjm-17 611 1 1975-2018 DATE bptjm-17 612 1 bethesda GPE bptjm-17 612 2 md, http://seer.cancer.gov/csr/ 1975_2017 GPE bptjm-17 612 3 november 2019 DATE bptjm-17 612 4 seer data ORG bptjm-17 612 5 april 2020 DATE bptjm-17 613 1 33 DATE bptjm-17 613 2 hu PERSON bptjm-17 613 3 x. GPE bptjm-17 613 4 dongyong ORG bptjm-17 613 5 yalun PERSON bptjm-17 613 6 l. PERSON bptjm-17 613 7 li PERSON bptjm-17 613 8 yan PERSON bptjm-17 613 9 w. PERSON bptjm-17 613 10 peng PERSON bptjm-17 613 11 x. GPE bptjm-17 614 1 august 2019 DATE bptjm-17 615 1 chinese NORP bptjm-17 616 1 16(3 CARDINAL bptjm-17 617 1 556–64 CARDINAL bptjm-17 618 1 hu PERSON bptjm-17 618 2 z. PERSON bptjm-17 618 3 chen PERSON bptjm-17 618 4 x. GPE bptjm-17 618 5 zhao PERSON bptjm-17 618 6 tian PERSON bptjm-17 618 7 t., jin GPE bptjm-17 618 8 berkeley pharma tech journal ORG bptjm-17 618 9 148 CARDINAL bptjm-17 618 10 xu PERSON bptjm-17 618 11 l. PERSON bptjm-17 618 12 zen ORG bptjm-17 618 13 k., zhang PERSON bptjm-17 618 14 h. PERSON bptjm-17 618 15 april 1, 2010 DATE bptjm-17 619 1 microrna ORG bptjm-17 620 1 1721 CARDINAL bptjm-17 622 1 2010 DATE bptjm-17 623 1 20194856 DATE bptjm-17 624 1 35 DATE bptjm-17 625 1 jeong PERSON bptjm-17 625 2 e. h. PERSON bptjm-17 625 3 lee PERSON bptjm-17 625 4 t. g. PERSON bptjm-17 625 5 ko PERSON bptjm-17 625 6 y. j. PERSON bptjm-17 625 7 kim PERSON bptjm-17 625 8 s. y. PERSON bptjm-17 625 9 kim PERSON bptjm-17 625 10 h. r. PERSON bptjm-17 625 11 kim PERSON bptjm-17 625 12 2018 DATE bptjm-17 626 1 cdk ORG bptjm-17 627 1 41(6 CARDINAL bptjm-17 627 2 663–675 CARDINAL bptjm-17 627 3 36 DATE bptjm-17 628 1 w. PERSON bptjm-17 628 2 xiang GPE bptjm-17 628 3 w. PERSON bptjm-17 628 4 x. GPE bptjm-17 628 5 shufan PERSON bptjm-17 628 6 honggang PERSON bptjm-17 628 7 d. GPE bptjm-17 628 8 january 29, 2020 DATE bptjm-17 631 1 121–26 CARDINAL bptjm-17 633 1 2019.11.050 CARDINAL bptjm-17 634 1 37 DATE bptjm-17 635 1 jiang PERSON bptjm-17 635 2 m., li PERSON bptjm-17 635 3 x. GPE bptjm-17 635 4 quan GPE bptjm-17 635 5 x. GPE bptjm-17 635 6 2018 DATE bptjm-17 637 1 9(17 CARDINAL bptjm-17 637 2 13948-13958 DATE bptjm-17 638 1 2018 DATE bptjm-17 638 2 jan 12 DATE bptjm-17 639 1 doi:10.18632/oncotarget.24189 38 ORG bptjm-17 640 1 m. PERSON bptjm-17 640 2 d. dejong GPE bptjm-17 640 3 a. burylo PERSON bptjm-17 640 4 j. a. burgers PERSON bptjm-17 640 5 baas ORG bptjm-17 640 6 a. d. r. huitema PERSON bptjm-17 640 7 j. h. beijnen PERSON bptjm-17 640 8 j. h. m. schellens PERSON bptjm-17 641 1 november 1, 2011 DATE bptjm-17 642 1 brca1 GPE bptjm-17 642 2 ercc1 GPE bptjm-17 642 3 abraxas GPE bptjm-17 642 4 rap80 NORP bptjm-17 642 5 first ORDINAL bptjm-17 643 1 310–17 CARDINAL bptjm-17 644 1 10.1016 CARDINAL bptjm-17 644 2 j.lungcan.2011.03.016 GPE bptjm-17 645 1 39 CARDINAL bptjm-17 646 1 kato PERSON bptjm-17 646 2 erica marchlik PERSON bptjm-17 646 3 sheryl k. elkin PERSON bptjm-17 646 4 jennifer l. carter PERSON bptjm-17 646 5 razelle kurzrock PERSON bptjm-17 647 1 april 15, 2017 DATE bptjm-17 648 1 ret ORG bptjm-17 648 2 4,871 CARDINAL bptjm-17 649 1 23(8 CARDINAL bptjm-17 649 2 1988–97 DATE bptjm-17 651 1 40 DATE bptjm-17 652 1 kwak PERSON bptjm-17 652 2 p. b. PERSON bptjm-17 652 3 iwasaki GPE bptjm-17 652 4 s., & tomari ORG bptjm-17 652 5 2010 DATE bptjm-17 653 1 microrna ORG bptjm-17 654 1 2309–2315 CARDINAL bptjm-17 655 1 41 DATE bptjm-17 656 1 kim PERSON bptjm-17 656 2 nayoung GPE bptjm-17 656 3 mee song GPE bptjm-17 656 4 somin kim PERSON bptjm-17 656 5 yonghwan kim PERSON bptjm-17 656 6 yoon PERSON bptjm-17 657 1 november 20, 2015 DATE bptjm-17 659 1 367–75 DATE bptjm-17 661 1 42 CARDINAL bptjm-17 661 2 kishore PERSON bptjm-17 661 3 j., goel PERSON bptjm-17 661 4 m. k. PERSON bptjm-17 661 5 2010 DATE bptjm-17 662 1 kaplan meier ORG bptjm-17 663 1 1(4 CARDINAL bptjm-17 663 2 274 CARDINAL bptjm-17 663 3 43 DATE bptjm-17 664 1 krichevsky PERSON bptjm-17 664 2 2009 DATE bptjm-17 666 1 13(1 CARDINAL bptjm-17 666 2 39 CARDINAL bptjm-17 667 1 doi:10.1111 ORG bptjm-17 668 1 kris PERSON bptjm-17 668 2 m. g. PERSON bptjm-17 668 3 d. r. camidge PERSON bptjm-17 668 4 g. giaccone PERSON bptjm-17 668 5 t. hida PERSON bptjm-17 668 6 b. t. li PERSON bptjm-17 668 7 j. o’connell PERSON bptjm-17 668 8 i. taylor PERSON bptjm-17 669 1 july 1, 2015 DATE bptjm-17 671 1 1421–27 DATE bptjm-17 672 1 kodama PERSON bptjm-17 672 2 yasuko satoh PERSON bptjm-17 672 3 miyuki yoshida PERSON bptjm-17 672 4 yoshiaki watanabe GPE bptjm-17 672 5 osamu kondoh PERSON bptjm-17 672 6 hiroshi sakamoto PERSON bptjm-17 673 1 december 1, 2014 DATE bptjm-17 674 1 ret ORG bptjm-17 676 1 2910–18 CARDINAL bptjm-17 676 2 10.1158/1535-7163.mct-14-0274 DATE bptjm-17 677 1 berkeley pharma tech journal ORG bptjm-17 677 2 149 46 DATE bptjm-17 678 1 kohno PERSON bptjm-17 678 2 takashi PERSON bptjm-17 678 3 koji tsuta PERSON bptjm-17 678 4 katsuya tsuchihara ORG bptjm-17 678 5 takashi nakaoku PERSON bptjm-17 678 6 kiyotaka yoh PERSON bptjm-17 678 7 koichi PERSON bptjm-17 679 1 2013 DATE bptjm-17 680 1 ret ORG bptjm-17 681 1 104(11 CARDINAL bptjm-17 681 2 1396–1400 CARDINAL bptjm-17 682 1 https://doi.org/10.1111/cas.12275 ORG bptjm-17 683 1 47 CARDINAL bptjm-17 684 1 labbé ORG bptjm-17 684 2 m., korpanty PERSON bptjm-17 684 3 g. j. PERSON bptjm-17 684 4 m. k. PERSON bptjm-17 684 5 k. PERSON bptjm-17 684 6 b. PERSON bptjm-17 684 7 wang GPE bptjm-17 684 8 r. NORP bptjm-17 684 9 m. PERSON bptjm-17 684 10 n. b. PERSON bptjm-17 684 11 feld GPE bptjm-17 684 12 r. NORP bptjm-17 684 13 liu PERSON bptjm-17 684 14 bradbury GPE bptjm-17 684 15 p. a. PERSON bptjm-17 684 16 kamel-reid PERSON bptjm-17 684 17 s. PERSON bptjm-17 684 18 m. s. PERSON bptjm-17 684 19 f. a. PERSON bptjm-17 684 20 2017 CARDINAL bptjm-17 686 1 amsterdam GPE bptjm-17 686 2 netherlands GPE bptjm-17 686 3 111 CARDINAL bptjm-17 688 1 48 DATE bptjm-17 689 1 h. b. PERSON bptjm-17 689 2 w. y. PERSON bptjm-17 689 3 chen PERSON bptjm-17 689 4 d. d. NORP bptjm-17 689 5 j. y. PERSON bptjm-17 689 6 huang PERSON bptjm-17 689 7 liu PERSON bptjm-17 689 8 x. g. PERSON bptjm-17 689 9 y. k. PERSON bptjm-17 689 10 2012 DATE bptjm-17 690 1 mir-21 DATE bptjm-17 691 1 northwood GPE bptjm-17 691 2 london GPE bptjm-17 691 3 england GPE bptjm-17 691 4 29(5 CARDINAL bptjm-17 691 5 3190–3197 CARDINAL bptjm-17 693 1 li PERSON bptjm-17 693 2 m. x. PERSON bptjm-17 693 3 x. y. PERSON bptjm-17 693 4 zhao PERSON bptjm-17 693 5 h. PERSON bptjm-17 693 6 huang PERSON bptjm-17 693 7 z. PERSON bptjm-17 693 8 han NORP bptjm-17 693 9 zhao PERSON bptjm-17 693 10 d. b. PERSON bptjm-17 693 11 zhao PERSON bptjm-17 693 12 j. j. PERSON bptjm-17 693 13 j. q. PERSON bptjm-17 693 14 2016 DATE bptjm-17 694 1 1 CARDINAL bptjm-17 695 1 chinese NORP bptjm-17 695 2 129(5 CARDINAL bptjm-17 695 3 586–593 CARDINAL bptjm-17 697 1 50 CARDINAL bptjm-17 698 1 li PERSON bptjm-17 698 2 w. PERSON bptjm-17 698 3 wang PERSON bptjm-17 698 4 q. PERSON bptjm-17 698 5 tang PERSON bptjm-17 698 6 liu PERSON bptjm-17 698 7 x. GPE bptjm-17 698 8 dai ORG bptjm-17 698 9 2015 DATE bptjm-17 699 1 plos one PERSON bptjm-17 699 2 10(8 DATE bptjm-17 699 3 51 DATE bptjm-17 700 1 liang PERSON bptjm-17 700 2 l., zhu PERSON bptjm-17 700 3 w. PERSON bptjm-17 700 4 chen PERSON bptjm-17 700 5 x. GPE bptjm-17 700 6 luo, f. ( ORG bptjm-17 700 7 2019 DATE bptjm-17 701 1 mir-30a-5p PERSON bptjm-17 702 1 3711 CARDINAL bptjm-17 704 1 lin PERSON bptjm-17 704 2 q. GPE bptjm-17 704 3 zhang, h. ORG bptjm-17 704 4 ding, h. PERSON bptjm-17 704 5 qian PERSON bptjm-17 704 6 j. PERSON bptjm-17 704 7 lin PERSON bptjm-17 704 8 j. PERSON bptjm-17 704 9 han-zhang PERSON bptjm-17 704 10 xiang PERSON bptjm-17 704 11 j., li PERSON bptjm-17 704 12 2019 DATE bptjm-17 705 1 chinese NORP bptjm-17 706 1 17(1 CARDINAL bptjm-17 706 2 298 CARDINAL bptjm-17 707 1 53 DATE bptjm-17 708 1 liu PERSON bptjm-17 708 2 w. PERSON bptjm-17 708 3 zhuang PERSON bptjm-17 708 4 huang PERSON bptjm-17 708 5 t., yang GPE bptjm-17 708 6 m., lin PERSON bptjm-17 708 7 b. PERSON bptjm-17 708 8 jiang GPE bptjm-17 708 9 2020 DATE bptjm-17 708 10 9 CARDINAL bptjm-17 711 1 54 DATE bptjm-17 712 1 liu PERSON bptjm-17 712 2 heng-jia & ORG bptjm-17 712 3 patrick & du ORG bptjm-17 712 4 heng & speranza ORG bptjm-17 712 5 maria & vaughan ORG bptjm-17 712 6 spencer & alesi ORG bptjm-17 712 7 nicola & wong ORG bptjm-17 712 8 kwok-kin & freeman ORG bptjm-17 712 9 gordon & sharpe ORG bptjm-17 712 10 arlene & henske ORG bptjm-17 712 11 elizabeth PERSON bptjm-17 712 12 2018 DATE bptjm-17 713 1 1686 CARDINAL bptjm-17 715 1 1686-1686 PRODUCT bptjm-17 717 1 liu PERSON bptjm-17 717 2 chen, h. PERSON bptjm-17 717 3 q. PERSON bptjm-17 717 4 q. PERSON bptjm-17 717 5 wang, f. PERSON bptjm-17 717 6 wang PERSON bptjm-17 717 7 s. PERSON bptjm-17 717 8 s. PERSON bptjm-17 717 9 li PERSON bptjm-17 717 10 w., gu PERSON bptjm-17 717 11 2018 DATE bptjm-17 718 1 mir-145 PERSON bptjm-17 718 2 riok2 ORG bptjm-17 719 1 257 CARDINAL bptjm-17 721 1 liu xg PERSON bptjm-17 721 2 zhu wy PERSON bptjm-17 721 3 huang yy PERSON bptjm-17 721 4 ma PERSON bptjm-17 721 5 zhou sq PERSON bptjm-17 721 6 2012 DATE bptjm-17 721 7 29 CARDINAL bptjm-17 721 8 618-26 CARDINAL bptjm-17 721 9 57 DATE bptjm-17 722 1 luk ORG bptjm-17 722 2 c. i. PERSON bptjm-17 722 3 mahar, a., & cooper ORG bptjm-17 722 4 w. a. PERSON bptjm-17 722 5 2018 DATE bptjm-17 724 1 pathology & laboratory medicine ORG bptjm-17 724 2 142(8 CARDINAL bptjm-17 724 3 922–928 CARDINAL bptjm-17 725 1 https://doi.org/10.5858/ PERSON bptjm-17 725 2 s., & pantel ORG bptjm-17 725 3 2017 CARDINAL bptjm-17 726 1 berkeley pharma tech journal ORG bptjm-17 726 2 150 CARDINAL bptjm-17 726 3 40(7 CARDINAL bptjm-17 726 4 404–408 CARDINAL bptjm-17 727 1 58 DATE bptjm-17 728 1 madsen PERSON bptjm-17 728 2 a. t. PERSON bptjm-17 728 3 winther-larsen ORG bptjm-17 728 4 a. PERSON bptjm-17 728 5 mcculloch GPE bptjm-17 728 6 meldgaard, p., ORG bptjm-17 728 7 b. s. PERSON bptjm-17 728 8 2020 DATE bptjm-17 730 1 12(4 CARDINAL bptjm-17 730 2 947 CARDINAL bptjm-17 731 1 liu PERSON bptjm-17 731 2 s. PERSON bptjm-17 731 3 hu PERSON bptjm-17 731 4 l. GPE bptjm-17 731 5 wang, h. ORG bptjm-17 731 6 guo PERSON bptjm-17 731 7 m. PERSON bptjm-17 731 8 xu PERSON bptjm-17 731 9 2018 DATE bptjm-17 732 1 mir-30 PERSON bptjm-17 732 2 biomed research international ORG bptjm-17 732 3 2018 DATE bptjm-17 733 1 60 CARDINAL bptjm-17 733 2 mao PERSON bptjm-17 733 3 xiaowei PERSON bptjm-17 733 4 zhou zhang PERSON bptjm-17 733 5 xiaoxuan zheng PERSON bptjm-17 733 6 fangfang xie PERSON bptjm-17 733 7 duan GPE bptjm-17 733 8 jiang GPE bptjm-17 733 9 shannon chuai PERSON bptjm-17 733 10 han han-zhang PERSON bptjm-17 733 11 baohui han PERSON bptjm-17 733 12 jiayuan sun PERSON bptjm-17 734 1 april 1, 2017 DATE bptjm-17 736 1 663–72 DATE bptjm-17 738 1 2016.11.2235. 61 CARDINAL bptjm-17 739 1 mlak GPE bptjm-17 739 2 r. NORP bptjm-17 739 3 t., GPE bptjm-17 739 4 brzozowska GPE bptjm-17 739 5 a. PERSON bptjm-17 739 6 homa-mlak PERSON bptjm-17 739 7 i. PERSON bptjm-17 739 8 m., & małecka massalska ORG bptjm-17 739 9 t. GPE bptjm-17 739 10 2018 DATE bptjm-17 741 1 657–667 CARDINAL bptjm-17 741 2 62 CARDINAL bptjm-17 742 1 mo GPE bptjm-17 742 2 h. n. PERSON bptjm-17 742 3 2017 CARDINAL bptjm-17 744 1 3(3 CARDINAL bptjm-17 744 2 148–153 CARDINAL bptjm-17 745 1 63 DATE bptjm-17 745 2 munagala PERSON bptjm-17 745 3 aqil f PERSON bptjm-17 745 4 gupta rc PERSON bptjm-17 745 5 august 2016 DATE bptjm-17 747 1 10703-14 DATE bptjm-17 748 1 10.1007 CARDINAL bptjm-17 748 2 016-4939-8 CARDINAL bptjm-17 749 1 2016 feb 11 DATE bptjm-17 750 1 26867772 DATE bptjm-17 751 1 64 DATE bptjm-17 751 2 gerald f. PERSON bptjm-17 751 3 melike pekmezci PERSON bptjm-17 751 4 helen m. hansen PERSON bptjm-17 751 5 terri rice PERSON bptjm-17 751 6 roxanne e. marshall PERSON bptjm-17 751 7 annette m. molinaro PERSON bptjm-17 751 8 joanna j. phillips PERSON bptjm-17 752 1 may 1, 2015 DATE bptjm-17 754 1 journal of neuropathology & ORG bptjm-17 754 2 74(5 DATE bptjm-17 754 3 442–52 CARDINAL bptjm-17 757 1 remon PERSON bptjm-17 757 2 jordi PERSON bptjm-17 757 3 benjamin besse PERSON bptjm-17 757 4 alexandra leary PERSON bptjm-17 757 5 ivan bièche PERSON bptjm-17 757 6 bastien job PERSON bptjm-17 757 7 ludovic lacroix PERSON bptjm-17 758 1 september 1, 2020 DATE bptjm-17 759 1 2 CARDINAL bptjm-17 760 1 jto ORG bptjm-17 760 2 1(3 CARDINAL bptjm-17 760 3 100068 DATE bptjm-17 762 1 66 CARDINAL bptjm-17 763 1 ricciuti PERSON bptjm-17 763 2 b. PERSON bptjm-17 763 3 m., metro ORG bptjm-17 763 4 s., matocci ORG bptjm-17 763 5 r. NORP bptjm-17 763 6 m., & chiari ORG bptjm-17 763 7 2017 CARDINAL bptjm-17 764 1 ntrk ORG bptjm-17 765 1 northwood GPE bptjm-17 765 2 london GPE bptjm-17 765 3 england GPE bptjm-17 765 4 105 CARDINAL bptjm-17 766 1 67 CARDINAL bptjm-17 766 2 e., coco PERSON bptjm-17 766 3 s. PERSON bptjm-17 766 4 genova GPE bptjm-17 766 5 longo PERSON bptjm-17 766 6 l., & grossi ORG bptjm-17 766 7 f. PERSON bptjm-17 766 8 2019 DATE bptjm-17 768 1 12(1 CARDINAL bptjm-17 768 2 17 CARDINAL bptjm-17 768 3 68 CARDINAL bptjm-17 769 1 rinaldi a. ( PERSON bptjm-17 769 2 2011 DATE bptjm-17 772 1 12(6 CARDINAL bptjm-17 772 2 500–504 CARDINAL bptjm-17 773 1 berkeley pharma tech journal ORG bptjm-17 773 2 151 69 DATE bptjm-17 774 1 antonio & antognelli ORG bptjm-17 774 2 cinzia & covarelli ORG bptjm-17 774 3 piero & izzo ORG bptjm-17 774 4 luciano & vienna ORG bptjm-17 774 5 ludovini & annamaria ORG bptjm-17 774 6 siggillino & nicola ORG bptjm-17 774 7 talesa & svitlana ORG bptjm-17 774 8 2020 DATE bptjm-17 777 1 1-8 CARDINAL bptjm-17 778 1 70 DATE bptjm-17 779 1 saito PERSON bptjm-17 779 2 m. PERSON bptjm-17 779 3 a. j. PERSON bptjm-17 779 4 s. GPE bptjm-17 779 5 kohno GPE bptjm-17 779 6 t. GPE bptjm-17 779 7 bowman PERSON bptjm-17 779 8 e. d. PERSON bptjm-17 779 9 mathé GPE bptjm-17 779 10 e. a. PERSON bptjm-17 779 11 s., yokota ORG bptjm-17 779 12 j. GPE bptjm-17 779 13 haugen GPE bptjm-17 779 14 a., & harris ORG bptjm-17 779 15 c. c. PERSON bptjm-17 779 16 2011 DATE bptjm-17 780 1 three CARDINAL bptjm-17 781 1 the american association ORG bptjm-17 781 2 1875–1882 DATE bptjm-17 782 1 71 DATE bptjm-17 783 1 m. i. PERSON bptjm-17 783 2 a. PERSON bptjm-17 783 3 barlési ORG bptjm-17 783 4 f. PERSON bptjm-17 783 5 j., marquette ORG bptjm-17 783 6 c. h. PERSON bptjm-17 783 7 2013 DATE bptjm-17 784 1 two CARDINAL bptjm-17 785 1 plos one PERSON bptjm-17 785 2 8(1 CARDINAL bptjm-17 786 1 10.1371/journal.pone.0054596 72 DATE bptjm-17 787 1 santiago-walker ORG bptjm-17 787 2 ademi & moy ORG bptjm-17 787 3 christopher & cherkas ORG bptjm-17 787 4 yauheniya & loriot ORG bptjm-17 787 5 yohann & ORG bptjm-17 787 6 arlene & ORG bptjm-17 787 7 ord & avadhani ORG bptjm-17 787 8 anjali & ohagan, anne & porre ORG bptjm-17 787 9 peter & lorenzi ORG bptjm-17 787 10 matthew & mcca ORG bptjm-17 787 11 ian NORP bptjm-17 787 12 2019 DATE bptjm-17 789 1 37 CARDINAL bptjm-17 789 2 420 CARDINAL bptjm-17 790 1 10.1200 CARDINAL bptjm-17 791 1 2019.37.7_suppl.420. DATE bptjm-17 792 1 73 DATE bptjm-17 793 1 satoh PERSON bptjm-17 793 2 n. ORG bptjm-17 793 3 nishimura ORG bptjm-17 793 4 k. GPE bptjm-17 793 5 nishio PERSON bptjm-17 793 6 w. GPE bptjm-17 793 7 m., okita PERSON bptjm-17 793 8 hurwitz PERSON bptjm-17 793 9 j., & hayashi ORG bptjm-17 793 10 2011 DATE bptjm-17 794 1 wip1 PERSON bptjm-17 795 1 102(5 DATE bptjm-17 795 2 1101–1106 DATE bptjm-17 797 1 74 CARDINAL bptjm-17 797 2 l. v., PERSON bptjm-17 797 3 von pawel PERSON bptjm-17 797 4 j. PERSON bptjm-17 797 5 e. g. PERSON bptjm-17 797 6 w. l. PERSON bptjm-17 797 7 brugger PERSON bptjm-17 797 8 w. PERSON bptjm-17 797 9 ferrari ORG bptjm-17 797 10 d. NORP bptjm-17 797 11 chen PERSON bptjm-17 797 12 costa GPE bptjm-17 797 13 d. b. PERSON bptjm-17 797 14 d. e. PERSON bptjm-17 797 15 orlov ORG bptjm-17 797 16 s. PERSON bptjm-17 797 17 r. NORP bptjm-17 797 18 arthur GPE bptjm-17 797 19 s. PERSON bptjm-17 797 20 gorbachevsky PERSON bptjm-17 797 21 i. GPE bptjm-17 797 22 schwartz GPE bptjm-17 797 23 b., & schiller ORG bptjm-17 797 24 j. h. ( PERSON bptjm-17 797 25 2011 DATE bptjm-17 799 1 american NORP bptjm-17 799 2 3307–3315 DATE bptjm-17 801 1 75 CARDINAL bptjm-17 802 1 schildhaus h. u. ( ORG bptjm-17 802 2 2020 DATE bptjm-17 803 1 immunhistochemiebasierte prädiktive biomarker bei ORG bptjm-17 804 1 der pathologe PERSON bptjm-17 804 2 41(1 ORG bptjm-17 804 3 21–31 CARDINAL bptjm-17 805 1 https://doi.org/10.1007/s00292-020-00750-7 76 DATE bptjm-17 806 1 shaw ORG bptjm-17 806 2 a. t. PERSON bptjm-17 806 3 b. y. PERSON bptjm-17 806 4 solomon PERSON bptjm-17 806 5 b. j. PERSON bptjm-17 806 6 g. j. PERSON bptjm-17 806 7 j. PERSON bptjm-17 806 8 j. a. PERSON bptjm-17 806 9 shapiro, g. i. PERSON bptjm-17 806 10 costa GPE bptjm-17 806 11 d. b. PERSON bptjm-17 806 12 s. h. PERSON bptjm-17 806 13 m. PERSON bptjm-17 806 14 salgia GPE bptjm-17 806 15 r. NORP bptjm-17 806 16 r. g. PERSON bptjm-17 806 17 garcia PERSON bptjm-17 806 18 m. PERSON bptjm-17 806 19 r. c. PERSON bptjm-17 806 20 y. j. PERSON bptjm-17 806 21 k. PERSON bptjm-17 806 22 wilner PERSON bptjm-17 806 23 k. d. PERSON bptjm-17 806 24 kwak GPE bptjm-17 806 25 e. l. PERSON bptjm-17 806 26 d. r. NORP bptjm-17 806 27 2011 DATE bptjm-17 808 1 lancet ORG bptjm-17 809 1 12(11 CARDINAL bptjm-17 809 2 1004–1012 CARDINAL bptjm-17 809 3 10.1016 CARDINAL bptjm-17 809 4 2045(11)70232 CARDINAL bptjm-17 810 1 shi gl PERSON bptjm-17 810 2 zhang xy PERSON bptjm-17 810 3 chen y PERSON bptjm-17 810 4 ma s PERSON bptjm-17 810 5 bai wq PERSON bptjm-17 810 6 yin yj PERSON bptjm-17 810 7 june 1, 2020 DATE bptjm-17 812 1 clin PERSON bptjm-17 812 2 66(6 CARDINAL bptjm-17 813 1 10.7754 CARDINAL bptjm-17 813 2 clin.lab.2019.191129 GPE bptjm-17 814 1 32538046 DATE bptjm-17 816 1 andrea sartore-bianchi PERSON bptjm-17 816 2 rebecca j. nagy PERSON bptjm-17 816 3 kanwal raghav PERSON bptjm-17 816 4 justin i. odegaard PERSON bptjm-17 816 5 richard b. lanman PERSON bptjm-17 816 6 livio trusolino PERSON bptjm-17 816 7 silvia marsoni PERSON bptjm-17 816 8 salvatore siena PERSON bptjm-17 816 9 alberto bardelli PERSON bptjm-17 817 1 may 15, 2019 DATE bptjm-17 819 1 25(10 CARDINAL bptjm-17 819 2 3046–53 CARDINAL bptjm-17 821 1 berkeley pharma tech journal ORG bptjm-17 821 2 152 79 CARDINAL bptjm-17 822 1 sromek m PERSON bptjm-17 822 2 glogowski m PERSON bptjm-17 822 3 kulinczak m ORG bptjm-17 822 4 szafron l ORG bptjm-17 822 5 zakrzewska k PERSON bptjm-17 822 6 wisniewski p PERSON bptjm-17 822 7 talarek l ORG bptjm-17 823 1 october 2017 DATE bptjm-17 824 1 mir-16 GPE bptjm-17 826 1 10.1007 CARDINAL bptjm-17 827 1 2017 CARDINAL bptjm-17 828 1 28634901 DATE bptjm-17 829 1 80 CARDINAL bptjm-17 829 2 jenny berry PERSON bptjm-17 829 3 michael roxas PERSON bptjm-17 829 4 nandita guha-thakurta PERSON bptjm-17 829 5 ishwaria mohan PERSON bptjm-17 829 6 siraj m. ali PERSON bptjm-17 829 7 caitlin mcmahon PERSON bptjm-17 829 8 july 1, 2015 DATE bptjm-17 830 1 ret ORG bptjm-17 830 2 kif5b GPE bptjm-17 831 1 89(1 DATE bptjm-17 833 1 81 CARDINAL bptjm-17 834 1 peter stein PERSON bptjm-17 835 1 n.d. GPE bptjm-17 838 1 u.s. GPE bptjm-17 838 2 food and drug administration ORG bptjm-17 840 1 tao PERSON bptjm-17 840 2 j. PERSON bptjm-17 840 3 sun PERSON bptjm-17 840 4 d. NORP bptjm-17 840 5 dong, l., zhu, h., & hou PERSON bptjm-17 840 6 2020 DATE bptjm-17 841 1 nf1 ORG bptjm-17 842 1 20 CARDINAL bptjm-17 842 2 492 CARDINAL bptjm-17 844 1 teresi GPE bptjm-17 844 2 chung-wai ORG bptjm-17 844 3 ching-shih chen PERSON bptjm-17 844 4 krishna chatterjee PERSON bptjm-17 844 5 kristin a. waite PERSON bptjm-17 844 6 eng PERSON bptjm-17 845 1 2006 DATE bptjm-17 846 1 lovastatin ORG bptjm-17 846 2 rosiglitazone. ORG bptjm-17 847 1 2390–98 CARDINAL bptjm-17 848 1 https://doi.org/10.1002/ijc.21799 DATE bptjm-17 849 1 84 CARDINAL bptjm-17 850 1 thompson ORG bptjm-17 850 2 rey c. PERSON bptjm-17 850 3 stephanie s. yee PERSON bptjm-17 850 4 andrea b. troxel PERSON bptjm-17 850 5 samantha l. savitch PERSON bptjm-17 850 6 ryan PERSON bptjm-17 850 7 david balli PERSON bptjm-17 850 8 david b. lieberman PERSON bptjm-17 851 1 december 1, DATE bptjm-17 851 2 2016 DATE bptjm-17 853 1 the american association ORG bptjm-17 853 2 5772–82 CARDINAL bptjm-17 855 1 tian f PERSON bptjm-17 855 2 wang j PERSON bptjm-17 855 3 ouyang t PERSON bptjm-17 855 4 2019 DATE bptjm-17 856 1 5p CARDINAL bptjm-17 857 1 10(688 CARDINAL bptjm-17 858 1 2019 CARDINAL bptjm-17 859 1 86 CARDINAL bptjm-17 860 1 kenneth k. w. PERSON bptjm-17 860 2 william k. k. wu PERSON bptjm-17 860 3 herbert h. f. loong PERSON bptjm-17 861 1 march 15, 2018 DATE bptjm-17 862 1 ppargamma PERSON bptjm-17 863 1 european journal of pharmacology ORG bptjm-17 863 2 823 CARDINAL bptjm-17 863 3 19–26 CARDINAL bptjm-17 865 1 87 CARDINAL bptjm-17 866 1 veldore ORG bptjm-17 866 2 anuradha choughule PERSON bptjm-17 866 3 tejaswi DATE bptjm-17 866 4 nitin mandloi PERSON bptjm-17 866 5 vanita noronha ORG bptjm-17 866 6 amit joshi PERSON bptjm-17 866 7 amit dutt PERSON bptjm-17 866 8 ravi gupta PERSON bptjm-17 866 9 kumar prabhash PERSON bptjm-17 867 1 january 3, 2018 DATE bptjm-17 869 1 9 CARDINAL bptjm-17 869 2 1–11 CARDINAL bptjm-17 871 1 88 CARDINAL bptjm-17 872 1 vincent PERSON bptjm-17 872 2 m. d. PERSON bptjm-17 872 3 kuruvilla PERSON bptjm-17 872 4 m. s. PERSON bptjm-17 872 5 n. b. PERSON bptjm-17 872 6 kamel-reid PERSON bptjm-17 872 7 s. PERSON bptjm-17 872 8 2012 DATE bptjm-17 873 1 alk ORG bptjm-17 873 2 kras ORG bptjm-17 874 1 toronto GPE bptjm-17 874 2 1 CARDINAL bptjm-17 877 1 wang ORG bptjm-17 877 2 hu PERSON bptjm-17 877 3 wang PERSON bptjm-17 877 4 s. PERSON bptjm-17 877 5 shen GPE bptjm-17 877 6 j., & wang ORG bptjm-17 877 7 x. GPE bptjm-17 877 8 2020 DATE bptjm-17 879 1 139 CARDINAL bptjm-17 882 1 wang, h., ORG bptjm-17 882 2 peng PERSON bptjm-17 882 3 r. NORP bptjm-17 882 4 wang PERSON bptjm-17 882 5 j., qin PERSON bptjm-17 882 6 z., & xue ORG bptjm-17 882 7 2018 DATE bptjm-17 884 1 berkeley pharma tech journal ORG bptjm-17 884 2 153 CARDINAL bptjm-17 884 3 10 CARDINAL bptjm-17 884 4 59 DATE bptjm-17 885 1 91 DATE bptjm-17 886 1 wang ORG bptjm-17 886 2 j., tian PERSON bptjm-17 886 3 x. GPE bptjm-17 886 4 han NORP bptjm-17 886 5 r. et al PERSON bptjm-17 886 6 2014 DATE bptjm-17 887 1 5p CARDINAL bptjm-17 887 2 arhgap5 PERSON bptjm-17 888 1 33 DATE bptjm-17 888 2 1181–1189 DATE bptjm-17 889 1 92 CARDINAL bptjm-17 890 1 wang y PERSON bptjm-17 890 2 zeng g PERSON bptjm-17 890 3 jiang y. PERSON bptjm-17 890 4 2020 DATE bptjm-17 892 1 12 DATE bptjm-17 892 2 1079-1088 DATE bptjm-17 893 1 2020 DATE bptjm-17 893 2 feb 12 DATE bptjm-17 894 1 93 CARDINAL bptjm-17 895 1 wang ORG bptjm-17 895 2 wang PERSON bptjm-17 895 3 li PERSON bptjm-17 895 4 j., li PERSON bptjm-17 895 5 j., & che ORG bptjm-17 895 6 2020 DATE bptjm-17 896 1 biomed research international ORG bptjm-17 896 2 2020 DATE bptjm-17 896 3 3608241 DATE bptjm-17 898 1 wang zx PERSON bptjm-17 898 2 bian hb PERSON bptjm-17 898 3 wang jr, cheng zx PERSON bptjm-17 898 4 wang km PERSON bptjm-17 898 5 de w. PERSON bptjm-17 898 6 december 2011 DATE bptjm-17 899 1 mirna-21 DATE bptjm-17 900 1 j surg oncol PERSON bptjm-17 900 2 104(7):847 CARDINAL bptjm-17 901 1 10.1002 CARDINAL bptjm-17 902 1 2011 DATE bptjm-17 902 2 30 CARDINAL bptjm-17 903 1 2172101 95 DATE bptjm-17 904 1 wang ORG bptjm-17 904 2 2020 DATE bptjm-17 906 1 38(15 CARDINAL bptjm-17 907 1 doi:10.1200/jco.2020.38.15_suppl.e21647 ORG bptjm-17 908 1 96 DATE bptjm-17 909 1 f. m. PERSON bptjm-17 909 2 l. s. m. wong PERSON bptjm-17 909 3 w. timens PERSON bptjm-17 909 4 h. h. kampinga PERSON bptjm-17 909 5 h. j. m. groen PERSON bptjm-17 910 1 november 2005 DATE bptjm-17 911 1 ercc1 PERSON bptjm-17 911 2 brca1 GPE bptjm-17 912 1 amsterdam GPE bptjm-17 912 2 netherlands GPE bptjm-17 912 3 211–19 DATE bptjm-17 915 1 d. l. PERSON bptjm-17 915 2 f. m. PERSON bptjm-17 915 3 2014 DATE bptjm-17 917 1 clifton GPE bptjm-17 917 2 n.j. GPE bptjm-17 917 3 1099 DATE bptjm-17 917 4 65–75 CARDINAL bptjm-17 917 5 10.1007/978 CARDINAL bptjm-17 917 6 wei j PERSON bptjm-17 917 7 gao w PERSON bptjm-17 917 8 zhu cj PERSON bptjm-17 917 9 liu yq PERSON bptjm-17 917 10 cheng t PERSON bptjm-17 917 11 shu yq ORG bptjm-17 918 1 june 2011 DATE bptjm-17 919 1 identi PERSON bptjm-17 919 2 microrna-21 DATE bptjm-17 920 1 chin j PERSON bptjm-17 920 2 407 CARDINAL bptjm-17 921 1 10.5732 CARDINAL bptjm-17 923 1 21627863 DATE bptjm-17 924 1 98 CARDINAL bptjm-17 925 1 shiwang PERSON bptjm-17 925 2 lei dai PERSON bptjm-17 925 3 lei wang PERSON bptjm-17 925 4 wenjian wang PERSON bptjm-17 925 5 duoguang wu PERSON bptjm-17 925 6 kefeng wang PERSON bptjm-17 925 7 zhanghai GPE bptjm-17 926 1 november 2019 DATE bptjm-17 927 1 chinese NORP bptjm-17 928 1 24(11 CARDINAL bptjm-17 929 1 99 CARDINAL bptjm-17 930 1 xie PERSON bptjm-17 930 2 li PERSON bptjm-17 930 3 x. GPE bptjm-17 930 4 x. GPE bptjm-17 930 5 sun PERSON bptjm-17 930 6 x. GPE bptjm-17 930 7 wang PERSON bptjm-17 930 8 2016 CARDINAL bptjm-17 934 1 2016.03.010 100 CARDINAL bptjm-17 935 1 xu PERSON bptjm-17 935 2 s., & xu ORG bptjm-17 935 3 s. PERSON bptjm-17 935 4 2019 DATE bptjm-17 937 1 18 CARDINAL bptjm-17 937 2 758 CARDINAL bptjm-17 938 1 10.3892 CARDINAL bptjm-17 940 1 yang PERSON bptjm-17 940 2 nong PERSON bptjm-17 940 3 zhidong liu PERSON bptjm-17 940 4 hao qin PERSON bptjm-17 941 1 march 23, 2018 DATE bptjm-17 943 1 18(1 CARDINAL bptjm-17 943 2 319 CARDINAL bptjm-17 944 1 102 CARDINAL bptjm-17 945 1 yarlagadda ORG bptjm-17 945 2 vaishnavi kamatham ORG bptjm-17 945 3 ashton ritter PERSON bptjm-17 945 4 faisal shahjehan PERSON bptjm-17 945 5 m. kasi PERSON bptjm-17 946 1 august 19, 2019 DATE bptjm-17 947 1 trastuzumab PERSON bptjm-17 947 2 ed her2 PERSON bptjm-17 948 1 3(1 CARDINAL bptjm-17 949 1 103 CARDINAL bptjm-17 950 1 yuxia m PERSON bptjm-17 950 2 zhennan t GPE bptjm-17 950 3 wei z. PERSON bptjm-17 950 4 december 2012 DATE bptjm-17 951 1 berkeley pharma tech journal ORG bptjm-17 951 2 154 CARDINAL bptjm-17 952 1 138(12):2045-50 CARDINAL bptjm-17 954 1 2012 jul 18 DATE bptjm-17 955 1 22806310 DATE bptjm-17 957 1 zeng PERSON bptjm-17 957 2 hanlin PERSON bptjm-17 957 3 aparna jorapur PERSON bptjm-17 957 4 a. hunter shain PERSON bptjm-17 957 5 ursula e. lang PERSON bptjm-17 957 6 rodrigo torres PERSON bptjm-17 957 7 yuntian zhang PERSON bptjm-17 957 8 andrew s. mcneal PERSON bptjm-17 957 9 july 9, 2018 DATE bptjm-17 959 1 34(1 CARDINAL bptjm-17 959 2 56-68.e9 CARDINAL bptjm-17 961 1 105 CARDINAL bptjm-17 962 1 g. b. PERSON bptjm-17 962 2 chen PERSON bptjm-17 962 3 j. PERSON bptjm-17 962 4 wang PERSON bptjm-17 962 5 l. r. PERSON bptjm-17 962 6 li PERSON bptjm-17 962 7 j., li PERSON bptjm-17 962 8 m. w. PERSON bptjm-17 962 9 xu PERSON bptjm-17 962 10 n. PERSON bptjm-17 962 11 wang PERSON bptjm-17 962 12 j. z. PERSON bptjm-17 962 13 2012 DATE bptjm-17 963 1 rrm1 PERSON bptjm-17 963 2 ercc1 PERSON bptjm-17 964 1 69(5 DATE bptjm-17 964 2 1277–1287 DATE bptjm-17 965 1 106 CARDINAL bptjm-17 966 1 roth PERSON bptjm-17 966 2 j. a. PERSON bptjm-17 966 3 yu, h. ORG bptjm-17 966 4 xie PERSON bptjm-17 966 5 k. PERSON bptjm-17 966 6 zhao PERSON bptjm-17 966 7 chang PERSON bptjm-17 966 8 d. w. PERSON bptjm-17 966 9 huang PERSON bptjm-17 966 10 m., li PERSON bptjm-17 966 11 j., & wu ORG bptjm-17 966 12 x. GPE bptjm-17 966 13 2019 DATE bptjm-17 967 1 5 CARDINAL bptjm-17 968 1 643–650 CARDINAL bptjm-17 969 1 107 CARDINAL bptjm-17 970 1 zhao PERSON bptjm-17 970 2 m., zhang PERSON bptjm-17 970 3 liang PERSON bptjm-17 970 4 j., chen PERSON bptjm-17 970 5 yang PERSON bptjm-17 970 6 liang PERSON bptjm-17 970 7 x. GPE bptjm-17 970 8 cai, h., & liu ORG bptjm-17 970 9 w. PERSON bptjm-17 970 10 2016 CARDINAL bptjm-17 971 1 wip1 PERSON bptjm-17 972 1 11(4 DATE bptjm-17 972 2 2365–2370 CARDINAL bptjm-17 974 1 2016.4245 CARDINAL bptjm-17 975 1 108 CARDINAL bptjm-17 976 1 zhao w PERSON bptjm-17 976 2 zhao jj, zhang l PERSON bptjm-17 976 3 xu qf PERSON bptjm-17 976 4 zhao ym PERSON bptjm-17 976 5 shi xy PERSON bptjm-17 976 6 xu ag ORG bptjm-17 976 7 2015 CARDINAL bptjm-17 977 1 mir-21 DATE bptjm-17 979 1 j clin PERSON bptjm-17 979 2 2015 109 DATE bptjm-17 980 1 w. PERSON bptjm-17 980 2 luo PERSON bptjm-17 980 3 b. PERSON bptjm-17 980 4 j. PERSON bptjm-17 980 5 j., chen PERSON bptjm-17 980 6 d. NORP bptjm-17 980 7 xu PERSON bptjm-17 980 8 l. PERSON bptjm-17 981 1 zhang PERSON bptjm-17 981 2 2014 DATE bptjm-17 983 1 32(8 CARDINAL bptjm-17 983 2 394 CARDINAL bptjm-17 984 1 berkeley pharma tech journal ORG bptjm-17 984 2 155 2 CARDINAL bptjm-17 984 3 1).pdf CARDINAL bptjm-17 984 4 1).pdf CARDINAL